Labeling Type,Dosage Form(s),Route(s) of Administration,Marketing Category,Application Number(s),Trade Name,Generic/Proper Name(s),Most Recent SPL Date (YYYY/MM/DD),Established Pharmacologic Class(es),Initial U.S. Approval,Company,Marketing Date(s) (YYYY/MM/DD),NDC(s),Active Ingredient UNII(s),Active Ingredient(s),Active Moiety Name(s),Active Moiety UNII(s),FDALabel Link,DailyMed Link,DailyMed PDF Link,SET ID
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,205831,APTENSIO XR,(METHYLPHENIDATE HYDROCHLORIDE),20190621,Central Nervous System Stimulant,1955,RHODES PHARMACEUTICALS L P,2015/04/17-,42858-401; 42858-402; 42858-403; 42858-404; 42858-405; 42858-406; 42858-407,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/5adedc01-ebf0-11e3-ac10-0800200c9a66/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5adedc01-ebf0-11e3-ac10-0800200c9a66,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5adedc01-ebf0-11e3-ac10-0800200c9a66,5adedc01-ebf0-11e3-ac10-0800200c9a66
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89536,"ACETAMINOPHEN, BUTALBITAL AND CAFFEINE","ACETAMINOPHEN, BUTALBITAL AND CAFFEINE",20110209,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,STAT RX USA LLC,1988/02/16-,16590-022,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8e99c982-50ca-49d7-b80a-b60aa18401cb/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e99c982-50ca-49d7-b80a-b60aa18401cb,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e99c982-50ca-49d7-b80a-b60aa18401cb,8e99c982-50ca-49d7-b80a-b60aa18401cb
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,204209,"Acetaminophen, Caffeine and Dihydrocodeine Bitartrate","ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE",20190814,Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,,LARKEN LABORATORIES INC,2016/10/04-,68047-720,362O9ITL9D; 3G6A5W338E; 8LXS95BSA9,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE,362O9ITL9D; 3G6A5W338E; N9I9HDB855,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/28bb5975-32f6-414a-84ed-c376da575e3f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28bb5975-32f6-414a-84ed-c376da575e3f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28bb5975-32f6-414a-84ed-c376da575e3f,28bb5975-32f6-414a-84ed-c376da575e3f
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,204785,"Acetaminophen, Caffeine, Dihydrocodeine Bitartrate","ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE",20190508,Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,,XSPIRE PHARMA LLC,2015/08/05-,42195-840,362O9ITL9D; 3G6A5W338E; 8LXS95BSA9,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE,362O9ITL9D; 3G6A5W338E; N9I9HDB855,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/76e033b0-01c1-42df-bb64-f8ca401cfb6b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76e033b0-01c1-42df-bb64-f8ca401cfb6b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=76e033b0-01c1-42df-bb64-f8ca401cfb6b,76e033b0-01c1-42df-bb64-f8ca401cfb6b
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,204785,Trezix,"ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE",20190301,Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,,WRASER LLC,2014/12/01-,66992-840,362O9ITL9D; 3G6A5W338E; 8LXS95BSA9,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE,362O9ITL9D; 3G6A5W338E; N9I9HDB855,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a519a201-bcfd-4029-9bdf-fc3e03f975ac/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a519a201-bcfd-4029-9bdf-fc3e03f975ac,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a519a201-bcfd-4029-9bdf-fc3e03f975ac,a519a201-bcfd-4029-9bdf-fc3e03f975ac
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,204785,Trezix,"ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE",20181201,Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,,PROFICIENT RX LP,2014/12/01-,63187-705,362O9ITL9D; 3G6A5W338E; 8LXS95BSA9,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE,362O9ITL9D; 3G6A5W338E; N9I9HDB855,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/45c3c2a1-6a89-471e-b6d4-5a4cd73b987a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=45c3c2a1-6a89-471e-b6d4-5a4cd73b987a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45c3c2a1-6a89-471e-b6d4-5a4cd73b987a,45c3c2a1-6a89-471e-b6d4-5a4cd73b987a
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,204785,Trezix,"ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE",20170615,Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,,BRYANT RANCH PREPACK,2014/12/01-,63629-5637,362O9ITL9D; 3G6A5W338E; 8LXS95BSA9,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE,362O9ITL9D; 3G6A5W338E; N9I9HDB855,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f90f87cb-77ad-45f4-8b59-09459090d988/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f90f87cb-77ad-45f4-8b59-09459090d988,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f90f87cb-77ad-45f4-8b59-09459090d988,f90f87cb-77ad-45f4-8b59-09459090d988
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION, EXTENDED RELEASE",ORAL,NDA,208147,Dyanavel XR,AMPHETAMINE,20190206,Central Nervous System Stimulant,1960,TRIS PHARMA INC,2015/10/01-,27808-102,CK833KGX7E,AMPHETAMINE,AMPHETAMINE,CK833KGX7E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a8a7eb93-4192-4826-bbf1-82c06634f553/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8a7eb93-4192-4826-bbf1-82c06634f553,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a8a7eb93-4192-4826-bbf1-82c06634f553,a8a7eb93-4192-4826-bbf1-82c06634f553
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,204326,Adzenys XR-ODT,AMPHETAMINE,20180209,Central Nervous System Stimulant,1960,NEOS THERAPEUTICS LP,2016/02/16-,70165-005; 70165-010; 70165-015; 70165-020; 70165-025; 70165-030,CK833KGX7E,Amphetamine,Amphetamine,CK833KGX7E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c1179269-00b5-48ea-972d-31e614e99b7e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1179269-00b5-48ea-972d-31e614e99b7e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c1179269-00b5-48ea-972d-31e614e99b7e,c1179269-00b5-48ea-972d-31e614e99b7e
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION, EXTENDED RELEASE",ORAL,NDA,204325,Adzenys ER,AMPHETAMINE,20171208,Central Nervous System Stimulant,1960,NEOS THERAPEUTICS LP,2017/09/16-,70165-003,CK833KGX7E,Amphetamine,Amphetamine,CK833KGX7E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/eb1cc8d0-4231-41ea-8535-4fd872129713/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb1cc8d0-4231-41ea-8535-4fd872129713,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eb1cc8d0-4231-41ea-8535-4fd872129713,eb1cc8d0-4231-41ea-8535-4fd872129713
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200166,Evekeo,AMPHETAMINE SULFATE,20190814,Central Nervous System Stimulant,,ARBOR PHARMACEUTICALS,2015/11/01-,24338-022; 24338-026,6DPV8NK46S,Amphetamine Sulfate,Amphetamine,CK833KGX7E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f469fb38-0380-4621-9db3-a4f429126156/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f469fb38-0380-4621-9db3-a4f429126156,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f469fb38-0380-4621-9db3-a4f429126156,f469fb38-0380-4621-9db3-a4f429126156
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,88616,Butalbital Acetaminophen and Caffeine,BUTALBITAL ACETAMINOPHEN AND CAFFEINE,20181219,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC,2010/10/11-,49999-151,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f988e6f2-1e5b-416b-8f2a-aa45a3207945/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f988e6f2-1e5b-416b-8f2a-aa45a3207945,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f988e6f2-1e5b-416b-8f2a-aa45a3207945,f988e6f2-1e5b-416b-8f2a-aa45a3207945
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,Butalbital Acetaminophen and Caffeine,BUTALBITAL ACETAMINOPHEN AND CAFFEINE,20150515,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,NORTHWIND PHARMACEUTICALS,2015/05/13-,51655-590,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6bd940ca-bcc6-48e8-a98a-ddcea09a0e04/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6bd940ca-bcc6-48e8-a98a-ddcea09a0e04,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6bd940ca-bcc6-48e8-a98a-ddcea09a0e04,6bd940ca-bcc6-48e8-a98a-ddcea09a0e04
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,88616,Butalbital Acetaminophen and Caffeine,BUTALBITAL ACETAMINOPHEN AND CAFFEINE,20101011,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC,2010/10/11-,49999-151,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/418054c3-d8c8-49b0-93a5-a53fd0c5018f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=418054c3-d8c8-49b0-93a5-a53fd0c5018f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=418054c3-d8c8-49b0-93a5-a53fd0c5018f,418054c3-d8c8-49b0-93a5-a53fd0c5018f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40336,"Butalbital, Acetaminophen and Caffeine",BUTALBITAL AND ACETAMINOPHEN AND CAFFEINE,20100720,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,KELTMAN PHARMACEUTICALS INC,2007/08/29-,68387-520,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/faf741c4-bfc5-4f52-8773-c50f7b15dd08/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=faf741c4-bfc5-4f52-8773-c50f7b15dd08,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=faf741c4-bfc5-4f52-8773-c50f7b15dd08,faf741c4-bfc5-4f52-8773-c50f7b15dd08
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,89007,Zebutal,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20190701,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MAYNE PHARMA INC,2013/12/26-,68308-554,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ac7e8ce7-088f-4d9c-ad52-2af60436d836/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac7e8ce7-088f-4d9c-ad52-2af60436d836,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac7e8ce7-088f-4d9c-ad52-2af60436d836,ac7e8ce7-088f-4d9c-ad52-2af60436d836
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,89007,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20190701,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MAYNE PHARMA,2012/04/16-,51862-179,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/fa88f437-830b-48bc-a44c-fd142963a150/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa88f437-830b-48bc-a44c-fd142963a150,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fa88f437-830b-48bc-a44c-fd142963a150,fa88f437-830b-48bc-a44c-fd142963a150
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,89007,Esgic,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20190701,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MAYNE PHARMA INC,2014/05/01-,68308-219,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c5827155-c339-4f7e-829b-6cf4edc581af/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5827155-c339-4f7e-829b-6cf4edc581af,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5827155-c339-4f7e-829b-6cf4edc581af,c5827155-c339-4f7e-829b-6cf4edc581af
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,206615,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20190617,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,XSPIRE PHARMA LLC,2017/08/04-,42195-955,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/56d6c70e-b2c0-0276-e054-00144ff88e88/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56d6c70e-b2c0-0276-e054-00144ff88e88,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=56d6c70e-b2c0-0276-e054-00144ff88e88,56d6c70e-b2c0-0276-e054-00144ff88e88
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20190208,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MIKART LLC,1987/01/21-,46672-053,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a26775c2-cafb-4b13-99ac-d4e8248265fb/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a26775c2-cafb-4b13-99ac-d4e8248265fb,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a26775c2-cafb-4b13-99ac-d4e8248265fb,a26775c2-cafb-4b13-99ac-d4e8248265fb
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20181212,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,GOLDEN STATE MEDICAL SUPPLY INC,2018/01/08-,60429-589,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/2ed2e798-0d95-4ae2-a63d-2d66db009a71/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ed2e798-0d95-4ae2-a63d-2d66db009a71,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2ed2e798-0d95-4ae2-a63d-2d66db009a71,2ed2e798-0d95-4ae2-a63d-2d66db009a71
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20181201,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PROFICIENT RX LP,1987/01/21-,63187-520,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1bde13a5-cdd4-4bc2-8aeb-32e4dc157293/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1bde13a5-cdd4-4bc2-8aeb-32e4dc157293,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1bde13a5-cdd4-4bc2-8aeb-32e4dc157293,1bde13a5-cdd4-4bc2-8aeb-32e4dc157293
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20181127,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MAJOR PHARMACEUTICALS,1995/06/12-,0904-6538,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/19b523f6-6cfb-44a8-83d1-8bac5f7d6045/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=19b523f6-6cfb-44a8-83d1-8bac5f7d6045,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=19b523f6-6cfb-44a8-83d1-8bac5f7d6045,19b523f6-6cfb-44a8-83d1-8bac5f7d6045
HUMAN PRESCRIPTION DRUG LABEL,SYRUP,ORAL,ANDA,40387,Vanatol S,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20181127,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,GM PHARMACEUTICALS,2017/07/01-,58809-359,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/2e1c1554-61e9-4f46-ac18-e321e01adc0c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e1c1554-61e9-4f46-ac18-e321e01adc0c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2e1c1554-61e9-4f46-ac18-e321e01adc0c,2e1c1554-61e9-4f46-ac18-e321e01adc0c
HUMAN PRESCRIPTION DRUG LABEL,SYRUP,ORAL,ANDA,40387,Vanatol LQ,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20181120,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,GM PHARMACEUTICALS,2015/04/28-,58809-820,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/bc990056-c75f-4b0b-87f8-4fb9bdcd533c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc990056-c75f-4b0b-87f8-4fb9bdcd533c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc990056-c75f-4b0b-87f8-4fb9bdcd533c,bc990056-c75f-4b0b-87f8-4fb9bdcd533c
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,Esgic,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20181107,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MAYNE PHARMA INC,2014/05/01-,68308-220,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a41fa5cd-45c2-447b-b35f-aba505a67d98/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a41fa5cd-45c2-447b-b35f-aba505a67d98,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a41fa5cd-45c2-447b-b35f-aba505a67d98,a41fa5cd-45c2-447b-b35f-aba505a67d98
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20181024,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MAYNE PHARMA,2015/08/28-,51862-540,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a46ed1cb-830d-42f8-8ade-b41915d2c414/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a46ed1cb-830d-42f8-8ade-b41915d2c414,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a46ed1cb-830d-42f8-8ade-b41915d2c414,a46ed1cb-830d-42f8-8ade-b41915d2c414
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40511,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20181019,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,AMERICAN HEALTH PACKAGING,2009/09/08-,68084-396,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ed8079a1-670c-48fb-92ff-6e6ad51e6ad3/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed8079a1-670c-48fb-92ff-6e6ad51e6ad3,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed8079a1-670c-48fb-92ff-6e6ad51e6ad3,ed8079a1-670c-48fb-92ff-6e6ad51e6ad3
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40511,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20180831,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,CARDINAL HEALTH,2012/06/01-,55154-7147,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/92a81a1f-698b-4db0-b5a6-f7562abd9a32/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92a81a1f-698b-4db0-b5a6-f7562abd9a32,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=92a81a1f-698b-4db0-b5a6-f7562abd9a32,92a81a1f-698b-4db0-b5a6-f7562abd9a32
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20180719,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,NUCARE PHARMACEUTICALS INC,1987/01/21-,66267-039,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3d842708-32b3-18c8-e054-00144ff88e88/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d842708-32b3-18c8-e054-00144ff88e88,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3d842708-32b3-18c8-e054-00144ff88e88,3d842708-32b3-18c8-e054-00144ff88e88
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20180330,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PREFERRED PHARMACEUTICALS INC,2013/01/30-,68788-9711,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/71ab0446-3772-4680-93c5-8020d21dc15f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71ab0446-3772-4680-93c5-8020d21dc15f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=71ab0446-3772-4680-93c5-8020d21dc15f,71ab0446-3772-4680-93c5-8020d21dc15f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20180330,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PREFERRED PHARMACEUTICALS INC,1995/06/12-,68788-9025,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/41fbd224-1239-4d89-8e19-0a300cd66f38/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41fbd224-1239-4d89-8e19-0a300cd66f38,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=41fbd224-1239-4d89-8e19-0a300cd66f38,41fbd224-1239-4d89-8e19-0a300cd66f38
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20180222,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,APHENA PHARMA SOLUTIONS TENNESSEE LLC,2018/01/08-,71610-042,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e579dee5-bcf7-4f10-ac5d-13af5a06b12d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e579dee5-bcf7-4f10-ac5d-13af5a06b12d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e579dee5-bcf7-4f10-ac5d-13af5a06b12d,e579dee5-bcf7-4f10-ac5d-13af5a06b12d
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20180212,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,AVPAK,2017/07/21-,50268-139,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/83001953-2524-42be-9e90-f0b6a6852b6c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83001953-2524-42be-9e90-f0b6a6852b6c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=83001953-2524-42be-9e90-f0b6a6852b6c,83001953-2524-42be-9e90-f0b6a6852b6c
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20180125,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PD RX PHARMACEUTICALS INC,1995/06/12-,43063-369,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3c0c9e82-59f1-48f5-9aea-fb1ed5362ea4/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c0c9e82-59f1-48f5-9aea-fb1ed5362ea4,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c0c9e82-59f1-48f5-9aea-fb1ed5362ea4,3c0c9e82-59f1-48f5-9aea-fb1ed5362ea4
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20180101,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,BRYANT RANCH PREPACK,1987/01/21-,71335-0347,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a6e82fcc-578b-475b-bb49-8b0d837600f1/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6e82fcc-578b-475b-bb49-8b0d837600f1,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a6e82fcc-578b-475b-bb49-8b0d837600f1,a6e82fcc-578b-475b-bb49-8b0d837600f1
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20170929,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,WEST WARD PHARMACEUTICALS CORP,1995/06/12-,0143-1787,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/856d0894-e840-4b87-95aa-3085d5aed5be/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=856d0894-e840-4b87-95aa-3085d5aed5be,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=856d0894-e840-4b87-95aa-3085d5aed5be,856d0894-e840-4b87-95aa-3085d5aed5be
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20170511,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,ATLANTIC BIOLOGICALS CORPS,1995/06/12-,17856-1787,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/098f223d-842b-46d3-ab8b-5a998571c459/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=098f223d-842b-46d3-ab8b-5a998571c459,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=098f223d-842b-46d3-ab8b-5a998571c459,098f223d-842b-46d3-ab8b-5a998571c459
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,207118,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20170426,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MARLEX PHARMACEUTICALS INC,2017/04/01-,10135-628,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/5f6997ee-45d5-4ef9-a829-a284a35a4e72/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f6997ee-45d5-4ef9-a829-a284a35a4e72,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5f6997ee-45d5-4ef9-a829-a284a35a4e72,5f6997ee-45d5-4ef9-a829-a284a35a4e72
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,207118,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20161215,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,SUNRISE PHARMACEUTICAL INC,2017/01/10-,11534-187,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ee7630f8-f4b8-4eb0-b34d-d908567030c4/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee7630f8-f4b8-4eb0-b34d-d908567030c4,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee7630f8-f4b8-4eb0-b34d-d908567030c4,ee7630f8-f4b8-4eb0-b34d-d908567030c4
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20151030,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,DIRECT RX,2014/01/01-,61919-022,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c0a97823-63d5-43fa-862f-2acce3185681/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0a97823-63d5-43fa-862f-2acce3185681,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0a97823-63d5-43fa-862f-2acce3185681,c0a97823-63d5-43fa-862f-2acce3185681
HUMAN PRESCRIPTION DRUG LABEL,SYRUP,ORAL,ANDA,40387,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20131206,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MIKART INC,2003/01/31-,46672-633,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3f0f6064-cc9f-491c-a940-3f087abbc774/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f0f6064-cc9f-491c-a940-3f087abbc774,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3f0f6064-cc9f-491c-a940-3f087abbc774,3f0f6064-cc9f-491c-a940-3f087abbc774
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40511,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20110815,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,REDPHARM DRUG INC,2003/08/27-,67296-0718,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e8982243-5634-400a-8b23-8029fb4e5e92/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8982243-5634-400a-8b23-8029fb4e5e92,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e8982243-5634-400a-8b23-8029fb4e5e92,e8982243-5634-400a-8b23-8029fb4e5e92
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89175,"butalbital, acetaminophen and caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20110801,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,UNIT DOSE SERVICES,1987/01/21-,50436-4856,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/11690b28-5509-496a-9648-349158770ec2/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11690b28-5509-496a-9648-349158770ec2,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=11690b28-5509-496a-9648-349158770ec2,11690b28-5509-496a-9648-349158770ec2
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40496,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20110801,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,REBEL DISTRIBUTORS CORP,2003/12/23-,21695-843,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/917f576b-ead7-442d-bf90-7fb981210805/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=917f576b-ead7-442d-bf90-7fb981210805,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=917f576b-ead7-442d-bf90-7fb981210805,917f576b-ead7-442d-bf90-7fb981210805
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40336,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20100920,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,REBEL DISTRIBUTORS CORP,2009/12/15-,21695-257,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6dd09be6-a345-4a42-9b64-51b7808ff45f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6dd09be6-a345-4a42-9b64-51b7808ff45f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6dd09be6-a345-4a42-9b64-51b7808ff45f,6dd09be6-a345-4a42-9b64-51b7808ff45f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20100629,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PHYSICIANS TOTAL CARE INC,2004/06/21-,54868-1036,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8c330933-ee51-4261-917e-155fddf1b711/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c330933-ee51-4261-917e-155fddf1b711,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c330933-ee51-4261-917e-155fddf1b711,8c330933-ee51-4261-917e-155fddf1b711
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40513,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE PLUS","BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",20100521,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,STAT RX USA LLC,2003/08/25-,16590-581,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/eb1f2e22-5120-449f-9efb-7ac5a7c06bed/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb1f2e22-5120-449f-9efb-7ac5a7c06bed,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eb1f2e22-5120-449f-9efb-7ac5a7c06bed,eb1f2e22-5120-449f-9efb-7ac5a7c06bed
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40511,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20190611,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PD RX PHARMACEUTICALS INC,2003/08/27-,55289-879,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b1f56c61-1a51-48e2-a2f1-f15926284871/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1f56c61-1a51-48e2-a2f1-f15926284871,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1f56c61-1a51-48e2-a2f1-f15926284871,b1f56c61-1a51-48e2-a2f1-f15926284871
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20190321,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,NUCARE PHARMACEUTICALS INC,2012/09/13-,68071-3249,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4ecb7bdc-4a43-7444-e054-00144ff88e88/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ecb7bdc-4a43-7444-e054-00144ff88e88,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ecb7bdc-4a43-7444-e054-00144ff88e88,4ecb7bdc-4a43-7444-e054-00144ff88e88
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,204984,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20181207,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,ALVOGEN INC,2017/01/30-,47781-536,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,Acetaminophen; Butalbital; Caffeine,Acetaminophen; Butalbital; Caffeine,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/386ee445-35a8-78dd-e545-d101768607e3/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=386ee445-35a8-78dd-e545-d101768607e3,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=386ee445-35a8-78dd-e545-d101768607e3,386ee445-35a8-78dd-e545-d101768607e3
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20181201,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PROFICIENT RX LP,2012/09/13-,63187-933,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/7a2219a8-8aaf-44ad-9808-b67923df361a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a2219a8-8aaf-44ad-9808-b67923df361a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7a2219a8-8aaf-44ad-9808-b67923df361a,7a2219a8-8aaf-44ad-9808-b67923df361a
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,40885,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20180618,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,AVKARE INC,2014/11/24-,42291-181,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f5bbad36-6a0e-3518-3f12-138ae9f63980/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5bbad36-6a0e-3518-3f12-138ae9f63980,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f5bbad36-6a0e-3518-3f12-138ae9f63980,f5bbad36-6a0e-3518-3f12-138ae9f63980
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20180523,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,UNIT DOSE SERVICES,2012/09/13-,50436-1695,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b7e8a3c5-9da8-4609-9907-7de9e3243f7d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7e8a3c5-9da8-4609-9907-7de9e3243f7d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7e8a3c5-9da8-4609-9907-7de9e3243f7d,b7e8a3c5-9da8-4609-9907-7de9e3243f7d
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20180511,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,BRYANT RANCH PREPACK,2012/09/13-,71335-0365,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/65bc1e24-0409-45ad-8b57-afc73e215114/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=65bc1e24-0409-45ad-8b57-afc73e215114,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=65bc1e24-0409-45ad-8b57-afc73e215114,65bc1e24-0409-45ad-8b57-afc73e215114
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,88616,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20180403,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,UNIT DOSE SERVICES,2007/12/13-,50436-3369,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/673648ec-81ea-4f9f-a988-19016683aa6d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=673648ec-81ea-4f9f-a988-19016683aa6d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=673648ec-81ea-4f9f-a988-19016683aa6d,673648ec-81ea-4f9f-a988-19016683aa6d
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20180403,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PREFERRED PHARMACEUTICALS INC,2017/03/29-,68788-6939,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/85ce51e7-18c5-4ef2-8084-b1629dc32263/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=85ce51e7-18c5-4ef2-8084-b1629dc32263,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=85ce51e7-18c5-4ef2-8084-b1629dc32263,85ce51e7-18c5-4ef2-8084-b1629dc32263
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,88616,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20180402,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PREFERRED PHARMACEUTICALS INC,2015/05/08-,68788-9287,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d134544e-e54c-41fd-8c89-d7f017fb0829/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d134544e-e54c-41fd-8c89-d7f017fb0829,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d134544e-e54c-41fd-8c89-d7f017fb0829,d134544e-e54c-41fd-8c89-d7f017fb0829
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40511,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20171228,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,CARILION MATERIALS MANAGEMENT,2003/08/27-,68151-1313,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/97c50a3b-f954-46ed-9fa5-b9a45d485f1d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97c50a3b-f954-46ed-9fa5-b9a45d485f1d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=97c50a3b-f954-46ed-9fa5-b9a45d485f1d,97c50a3b-f954-46ed-9fa5-b9a45d485f1d
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,88616,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20170927,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,A S MEDICATION SOLUTIONS,2007/12/13-,50090-0371,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9a9fe1f1-eafd-44c9-923b-bea787b5e7e0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a9fe1f1-eafd-44c9-923b-bea787b5e7e0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a9fe1f1-eafd-44c9-923b-bea787b5e7e0,9a9fe1f1-eafd-44c9-923b-bea787b5e7e0
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40511,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20170419,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PAR PHARMACEUTICAL,2003/08/27-,0603-2544,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/aedc5167-cc3c-4044-87fa-4ed648c9f23f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aedc5167-cc3c-4044-87fa-4ed648c9f23f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aedc5167-cc3c-4044-87fa-4ed648c9f23f,aedc5167-cc3c-4044-87fa-4ed648c9f23f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20170310,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,NUCARE PHARMACEUTICALS INC,2012/09/13-,68071-3120,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4a638186-a9b4-0503-e054-00144ff8d46c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a638186-a9b4-0503-e054-00144ff8d46c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a638186-a9b4-0503-e054-00144ff8d46c,4a638186-a9b4-0503-e054-00144ff8d46c
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,40885,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20161116,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,ACTAVIS PHARMA INC,2013/07/29-,0591-2640,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ea5b9ffe-3cda-405e-8f75-3fd4a64c9a35/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea5b9ffe-3cda-405e-8f75-3fd4a64c9a35,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea5b9ffe-3cda-405e-8f75-3fd4a64c9a35,ea5b9ffe-3cda-405e-8f75-3fd4a64c9a35
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,40885,Fioricet,"BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20161116,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,ACTAVIS PHARMA INC,2013/07/29-,52544-080,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c018be7d-f7b8-45e2-97b8-8e7a71740657/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c018be7d-f7b8-45e2-97b8-8e7a71740657,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c018be7d-f7b8-45e2-97b8-8e7a71740657,c018be7d-f7b8-45e2-97b8-8e7a71740657
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20160818,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,LANNETT COMPANY INC,2012/09/13-,0527-1695,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/42594152-563e-4984-9901-d6ef3b8a6941/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42594152-563e-4984-9901-d6ef3b8a6941,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=42594152-563e-4984-9901-d6ef3b8a6941,42594152-563e-4984-9901-d6ef3b8a6941
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20150813,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,MEDSOURCE PHARMACEUTICALS,2012/09/13-,45865-352,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1d382246-ee7b-69cc-e054-00144ff8d46c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d382246-ee7b-69cc-e054-00144ff8d46c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1d382246-ee7b-69cc-e054-00144ff8d46c,1d382246-ee7b-69cc-e054-00144ff8d46c
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,200243,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20141107,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,RXCHANGE CO,2014/11/06-,33358-059,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f36970e8-9905-43cb-8cfd-693545f183cf/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f36970e8-9905-43cb-8cfd-693545f183cf,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f36970e8-9905-43cb-8cfd-693545f183cf,f36970e8-9905-43cb-8cfd-693545f183cf
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,88616,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20140801,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,ACTAVIS PHARMA INC,2007/12/13-,0591-3369,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a6cbc17f-5c60-489c-8029-84b0add556d8/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6cbc17f-5c60-489c-8029-84b0add556d8,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a6cbc17f-5c60-489c-8029-84b0add556d8,a6cbc17f-5c60-489c-8029-84b0add556d8
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40511,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20140602,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,APHENA PHARMA SOLUTIONS TENNESSEE LLC,2003/08/27-,67544-394,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1434df11-6e37-4722-a4c0-972e5c5899f8/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1434df11-6e37-4722-a4c0-972e5c5899f8,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1434df11-6e37-4722-a4c0-972e5c5899f8,1434df11-6e37-4722-a4c0-972e5c5899f8
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,40261,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20131119,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,WEST WARD PHARMACEUTICAL CORP,1998/10/28-,0143-0170,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/07b47cba-fadc-437e-9a9a-845ee1cce591/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07b47cba-fadc-437e-9a9a-845ee1cce591,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=07b47cba-fadc-437e-9a9a-845ee1cce591,07b47cba-fadc-437e-9a9a-845ee1cce591
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40513,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20121009,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,REBEL DISTRIBUTORS CORP,2003/08/25-,42254-323,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4b874a3d-db5a-40dc-a69c-d67c76b82b49/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b874a3d-db5a-40dc-a69c-d67c76b82b49,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b874a3d-db5a-40dc-a69c-d67c76b82b49,4b874a3d-db5a-40dc-a69c-d67c76b82b49
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20120329,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,STAT RX USA LLC,1995/06/12-,42549-553,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a04406b8-08fc-4d44-8b3c-63da3d7fb55b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a04406b8-08fc-4d44-8b3c-63da3d7fb55b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a04406b8-08fc-4d44-8b3c-63da3d7fb55b,a04406b8-08fc-4d44-8b3c-63da3d7fb55b
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40513,"Butalbital, Acetaminophen and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20110906,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,H J HARKINS COMPANY INC,2003/08/25-,52959-913,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/97768690-6a7f-4690-8684-371c89bea71c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97768690-6a7f-4690-8684-371c89bea71c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=97768690-6a7f-4690-8684-371c89bea71c,97768690-6a7f-4690-8684-371c89bea71c
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,89718,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20100920,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,REBEL DISTRIBUTORS CORP,1995/06/12-,21695-209,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,Acetaminophen; Butalbital; Caffeine,Acetaminophen; Butalbital; Caffeine,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/fef4844c-2b44-4e5c-9da3-e5b2214c9e8d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fef4844c-2b44-4e5c-9da3-e5b2214c9e8d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fef4844c-2b44-4e5c-9da3-e5b2214c9e8d,fef4844c-2b44-4e5c-9da3-e5b2214c9e8d
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,40885,ORBIVAN,"BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE",20100423,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,ATLEY PHARMACEUTICALS INC,2010/04/23-,59702-661,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d3c69436-a681-4e00-8db0-8cbfaac9627e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3c69436-a681-4e00-8db0-8cbfaac9627e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d3c69436-a681-4e00-8db0-8cbfaac9627e,d3c69436-a681-4e00-8db0-8cbfaac9627e
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,40885,"Butalbital, Acetaminophen, and Caffeine","BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES",20190906,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,NEXGEN PHARMA INC,2009/11/16-,0722-7029,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/611356c6-9cf6-4316-a9cb-e7756955755b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=611356c6-9cf6-4316-a9cb-e7756955755b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=611356c6-9cf6-4316-a9cb-e7756955755b,611356c6-9cf6-4316-a9cb-e7756955755b
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,206615,Phrenilin Forte,"BUTALBITAL, ACETAMINOPHEN, CAFFEINE",20190301,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,WRASER LLC,2017/09/18-,66992-955,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d8f3608b-814d-4f73-a64a-f60f59231a55/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8f3608b-814d-4f73-a64a-f60f59231a55,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d8f3608b-814d-4f73-a64a-f60f59231a55,d8f3608b-814d-4f73-a64a-f60f59231a55
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,76560,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",20190424,Barbiturate; Central Nervous System Stimulant; Methylxanthine,1992,BRECKENRIDGE PHARMACEUTICAL INC,2004/07/01-,51991-073,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,Acetaminophen; Butalbital; Caffeine; Codeine Phosphate,Acetaminophen; Butalbital; CODEINE ANHYDROUS; Caffeine,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d74db417-d2de-495b-bb75-46a83745603d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d74db417-d2de-495b-bb75-46a83745603d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d74db417-d2de-495b-bb75-46a83745603d,d74db417-d2de-495b-bb75-46a83745603d
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,76560,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",20180221,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,,BRYANT RANCH PREPACK,2004/07/01-,71335-0194,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/15a34df5-e48f-4570-9232-80e4093c4624/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15a34df5-e48f-4570-9232-80e4093c4624,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=15a34df5-e48f-4570-9232-80e4093c4624,15a34df5-e48f-4570-9232-80e4093c4624
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,76560,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",20111003,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,DISPENSING SOLUTIONS INC,2004/07/01-,68258-2012,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,Acetaminophen; Butalbital; Caffeine; Codeine Phosphate,Acetaminophen; Butalbital; Caffeine; Codeine,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; Q830PW7520,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/7fd761e6-64fe-44cc-8b74-10ce31ccfd66/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7fd761e6-64fe-44cc-8b74-10ce31ccfd66,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7fd761e6-64fe-44cc-8b74-10ce31ccfd66,7fd761e6-64fe-44cc-8b74-10ce31ccfd66
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,76560,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE",20190909,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,1992,NEXGEN PHARMA INC,2004/06/10-,0722-6670,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8c1edb39-1ae9-44f1-b23b-387b715a3df6/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c1edb39-1ae9-44f1-b23b-387b715a3df6,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c1edb39-1ae9-44f1-b23b-387b715a3df6,8c1edb39-1ae9-44f1-b23b-387b715a3df6
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,76560,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE",20190909,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,1992,NEXGEN PHARMA INC,2004/06/10-,0722-7028,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8f8c5c01-5859-4843-adf4-8116ddaedc90/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f8c5c01-5859-4843-adf4-8116ddaedc90,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f8c5c01-5859-4843-adf4-8116ddaedc90,8f8c5c01-5859-4843-adf4-8116ddaedc90
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,75929,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE",20190809,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,1992,PAR PHARMACEUTICAL,2002/04/22-,0603-2553,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6f8cced0-4749-4a11-8f00-96d8c23c1cfd/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f8cced0-4749-4a11-8f00-96d8c23c1cfd,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f8cced0-4749-4a11-8f00-96d8c23c1cfd,6f8cced0-4749-4a11-8f00-96d8c23c1cfd
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,76560,Fioricet with Codeine,"BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE",20190301,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,1992,ACTAVIS PHARMA INC,2013/07/29-,52544-082,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/df9801fc-03fe-41da-a6b3-0f76788217c9/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df9801fc-03fe-41da-a6b3-0f76788217c9,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df9801fc-03fe-41da-a6b3-0f76788217c9,df9801fc-03fe-41da-a6b3-0f76788217c9
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,76560,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE",20190301,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,1992,ACTAVIS PHARMA INC,2013/07/29-,0591-2641,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/52321fe5-c001-4e2d-8149-3197ddc13764/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=52321fe5-c001-4e2d-8149-3197ddc13764,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=52321fe5-c001-4e2d-8149-3197ddc13764,52321fe5-c001-4e2d-8149-3197ddc13764
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA authorized generic,20232,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE",20180627,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,1992,ACTAVIS PHARMA INC,2003/09/18-,0591-3220,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a58819b8-a52c-44a7-9ab0-c74480d98506/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a58819b8-a52c-44a7-9ab0-c74480d98506,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a58819b8-a52c-44a7-9ab0-c74480d98506,a58819b8-a52c-44a7-9ab0-c74480d98506
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA authorized generic,20232,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate","BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE",20171213,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,1992,BRYANT RANCH PREPACK,2003/09/18-,63629-3152,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3f0c092b-08db-4e8f-136a-456e0e7bec14/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f0c092b-08db-4e8f-136a-456e0e7bec14,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3f0c092b-08db-4e8f-136a-456e0e7bec14,3f0c092b-08db-4e8f-136a-456e0e7bec14
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,204195,"Butalbital, Aspirin and Caffeine","BUTALBITAL, ASPIRIN AND CAFFEINE",20181008,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,VENSUN PHARMACEUTICALS INC,2017/06/22-,42543-098,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,Aspirin; Butalbital; Caffeine,Aspirin; Butalbital; Caffeine,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ce47777f-8cf7-4f53-b48f-165b83516896/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce47777f-8cf7-4f53-b48f-165b83516896,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ce47777f-8cf7-4f53-b48f-165b83516896,ce47777f-8cf7-4f53-b48f-165b83516896
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,86162,"Butalbital, Aspirin and Caffeine","BUTALBITAL, ASPIRIN AND CAFFEINE",20120103,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,H J HARKINS COMPANY,1979/06/05-,52959-370,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/2ef4b16c-f553-4a79-b5ee-7893aeb0eae3/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ef4b16c-f553-4a79-b5ee-7893aeb0eae3,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2ef4b16c-f553-4a79-b5ee-7893aeb0eae3,2ef4b16c-f553-4a79-b5ee-7893aeb0eae3
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,86162,"Butalbital, Aspirin and Caffeine","BUTALBITAL, ASPIRIN AND CAFFEINE",20110929,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,DISPENSING SOLUTIONS INC,1979/06/05-,66336-619,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/657e4c4a-e50c-49f7-99b4-32395ec19bd8/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=657e4c4a-e50c-49f7-99b4-32395ec19bd8,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=657e4c4a-e50c-49f7-99b4-32395ec19bd8,657e4c4a-e50c-49f7-99b4-32395ec19bd8
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,86162,"Butalbital, Aspirin and Caffeine","BUTALBITAL, ASPIRIN AND CAFFEINE",20101210,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,REBEL DISTRIBUTORS CORP,2009/12/15-,21695-354,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4e10129b-41a3-4572-9564-6f8366b627dc/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e10129b-41a3-4572-9564-6f8366b627dc,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e10129b-41a3-4572-9564-6f8366b627dc,4e10129b-41a3-4572-9564-6f8366b627dc
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA authorized generic,17534,"Butalbital, Aspirin, and Caffeine","BUTALBITAL, ASPIRIN, AND CAFFEINE",20190913,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,ACTAVIS PHARMA INC,2003/10/06-,0591-3219,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e31096f4-162f-44bd-a211-9c2873acfe54/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e31096f4-162f-44bd-a211-9c2873acfe54,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e31096f4-162f-44bd-a211-9c2873acfe54,e31096f4-162f-44bd-a211-9c2873acfe54
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,86996,"Butalbital, aspirin, and caffeine","BUTALBITAL, ASPIRIN, AND CAFFEINE",20181218,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC,1985/10/11-,55700-129,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e334b580-ffc9-4ec7-836b-31b2211c730f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e334b580-ffc9-4ec7-836b-31b2211c730f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e334b580-ffc9-4ec7-836b-31b2211c730f,e334b580-ffc9-4ec7-836b-31b2211c730f
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,17534,Fiorinal,"BUTALBITAL, ASPIRIN, AND CAFFEINE",20181114,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,ACTAVIS PHARMA INC,completed:1976/05/04-2020/01/31,52544-955,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a00c6776-e9ef-411b-9396-915c3787559a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a00c6776-e9ef-411b-9396-915c3787559a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a00c6776-e9ef-411b-9396-915c3787559a,a00c6776-e9ef-411b-9396-915c3787559a
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,86996,"Butalbital, aspirin, and caffeine","BUTALBITAL, ASPIRIN, AND CAFFEINE",20171129,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,A S MEDICATION SOLUTIONS,1985/10/11-,50090-1580,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9e0df960-8a30-40e6-a9af-a92b9f09b11b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e0df960-8a30-40e6-a9af-a92b9f09b11b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e0df960-8a30-40e6-a9af-a92b9f09b11b,9e0df960-8a30-40e6-a9af-a92b9f09b11b
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,86996,"Butalbital, aspirin, and caffeine","BUTALBITAL, ASPIRIN, AND CAFFEINE",20170407,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,LANNETT COMPANY INC,1985/10/11-,0527-1552,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ba60b130-33cd-4db9-92a7-2cab8ded0737/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba60b130-33cd-4db9-92a7-2cab8ded0737,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ba60b130-33cd-4db9-92a7-2cab8ded0737,ba60b130-33cd-4db9-92a7-2cab8ded0737
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA authorized generic,17534,"Butalbital, Aspirin, and Caffeine","BUTALBITAL, ASPIRIN, AND CAFFEINE",20131223,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,AIDAREX PHARMACEUTICALS LLC,1976/05/04-,33261-922,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/166e131d-9c1a-461f-bf33-e45d4ec36ff2/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=166e131d-9c1a-461f-bf33-e45d4ec36ff2,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=166e131d-9c1a-461f-bf33-e45d4ec36ff2,166e131d-9c1a-461f-bf33-e45d4ec36ff2
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA authorized generic,17534,"BUTALBITAL, ASPIRIN, AND CAFFEINE","BUTALBITAL, ASPIRIN, AND CAFFEINE",20100922,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,STAT RX USA LLC,1976/05/04-,16590-911,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE,ASPIRIN; BUTALBITAL; CAFFEINE,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c69954d9-9b30-484f-8e4a-5b1fc7dd197d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c69954d9-9b30-484f-8e4a-5b1fc7dd197d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c69954d9-9b30-484f-8e4a-5b1fc7dd197d,c69954d9-9b30-484f-8e4a-5b1fc7dd197d
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,86231,"Butalbital, Aspirin, and Caffeine","BUTALBITAL, ASPIRIN, AND CAFFEINE",20100920,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,REBEL DISTRIBUTORS CORP,2003/09/18-,21695-139,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,aspirin; butalbital; caffeine,aspirin; butalbital; caffeine,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/aa9bfa49-c3b3-419d-a283-5ea0fd6fc3a0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa9bfa49-c3b3-419d-a283-5ea0fd6fc3a0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa9bfa49-c3b3-419d-a283-5ea0fd6fc3a0,aa9bfa49-c3b3-419d-a283-5ea0fd6fc3a0
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,75231,Ascomp with Codeine,"BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE",20190905,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor,1990,NEXGEN PHARMA INC,2001/11/30-,0722-6094,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ca3fe6e9-21ad-4fba-a602-e1c364cf3981/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca3fe6e9-21ad-4fba-a602-e1c364cf3981,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ca3fe6e9-21ad-4fba-a602-e1c364cf3981,ca3fe6e9-21ad-4fba-a602-e1c364cf3981
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,75231,Ascomp with Codeine,"BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",20190422,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,1990,BRECKENRIDGE PHARMACEUTICAL INC,2009/05/01-,51991-074,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,Aspirin; Butalbital; Caffeine; Codeine Phosphate,Aspirin; Butalbital; Caffeine; Codeine Anhydrous,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/243a6aea-0f48-42a9-a85e-ff247ab94336/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=243a6aea-0f48-42a9-a85e-ff247ab94336,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=243a6aea-0f48-42a9-a85e-ff247ab94336,243a6aea-0f48-42a9-a85e-ff247ab94336
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA authorized generic,19429,"Butalbital, Aspirin, Caffeine and Codeine Phosphate","BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",20180913,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor,1990,ACTAVIS PHARMA INC,2006/10/26-,0591-3546,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ad135f46-5490-40e9-9add-1a953c6d6a9d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad135f46-5490-40e9-9add-1a953c6d6a9d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ad135f46-5490-40e9-9add-1a953c6d6a9d,ad135f46-5490-40e9-9add-1a953c6d6a9d
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,75231,"BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE","BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",20171028,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor,,BRYANT RANCH PREPACK,2009/05/01-,63629-2952,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/95a33c9b-79a6-47c7-8433-fc217950b88f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95a33c9b-79a6-47c7-8433-fc217950b88f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95a33c9b-79a6-47c7-8433-fc217950b88f,95a33c9b-79a6-47c7-8433-fc217950b88f
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,74951,"Butalbital, Aspirin, Caffeine and Codeine Phosphate","BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",20120504,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor,,LANNETT COMPANY INC,1998/08/31-,0527-1312,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/04bddbc4-86c7-4bac-9327-010568020568/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04bddbc4-86c7-4bac-9327-010568020568,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=04bddbc4-86c7-4bac-9327-010568020568,04bddbc4-86c7-4bac-9327-010568020568
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,74359,"Butalbital, Aspirin, Caffeine and Codeine Phosphate","BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",20100629,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,PHYSICIANS TOTAL CARE INC,1998/06/02-,54868-1037,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE,3G6A5W338E; KHS0AZ4JVK; Q830PW7520; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/787cda7d-7aa4-4909-8e5c-f2fcf68828e4/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=787cda7d-7aa4-4909-8e5c-f2fcf68828e4,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=787cda7d-7aa4-4909-8e5c-f2fcf68828e4,787cda7d-7aa4-4909-8e5c-f2fcf68828e4
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,,,"Butalbital, Aspirin, Caffeine and Codeine Phosphate","BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",20071025,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,JEROME STEVENS PHARMACEUTICALS,,50564-507,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,Aspirin; Butalbital; Caffeine; Codeine Phosphate,Aspirin; Butalbital; Caffeine; Codeine,3G6A5W338E; KHS0AZ4JVK; Q830PW7520; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c8b93fc1-472c-4890-8d02-2ee4f7175c22/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8b93fc1-472c-4890-8d02-2ee4f7175c22,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8b93fc1-472c-4890-8d02-2ee4f7175c22,c8b93fc1-472c-4890-8d02-2ee4f7175c22
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,203335,"Butalbital, Aspirin, Caffeine, and Codeine Phosphate","BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE",20181227,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor,1990,MAYNE PHARMA INC,2015/10/30-,68308-312,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,Aspirin; Butalbital; Caffeine; Codeine Phosphate,Aspirin; Butalbital; Caffeine; Codeine Anhydrous,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3dd63865-af88-4cfe-a028-a21b3e65c25d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3dd63865-af88-4cfe-a028-a21b3e65c25d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3dd63865-af88-4cfe-a028-a21b3e65c25d,3dd63865-af88-4cfe-a028-a21b3e65c25d
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,19429,Fiorinal with Codeine,"BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE",20180903,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor,1990,ALLERGAN INC,1990/10/26-,0023-6010,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e6052c0f-5167-4a9e-8774-31d70b0a6bec/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6052c0f-5167-4a9e-8774-31d70b0a6bec,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6052c0f-5167-4a9e-8774-31d70b0a6bec,e6052c0f-5167-4a9e-8774-31d70b0a6bec
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,19429,Fiorinal with Codeine,"BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE",20170821,Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor,1990,ACTAVIS PHARMA INC,completed:1990/10/26-2020/03/31,52544-956,3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK; R16CO5Y76E,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE ANHYDROUS,3G6A5W338E; KHS0AZ4JVK; R16CO5Y76E; UX6OWY2V7J,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ace223cc-458e-4455-a64e-83e5cbf95f9a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ace223cc-458e-4455-a64e-83e5cbf95f9a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ace223cc-458e-4455-a64e-83e5cbf95f9a,ace223cc-458e-4455-a64e-83e5cbf95f9a
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,Unapproved drug other,,Caffeine and Sodium Benzoate,CAFFEINE AND SODIUM BENZOATE,20181219,Central Nervous System Stimulant; Methylxanthine,,AMERICAN REGENT INC,1993/02/01-,0517-2502,3G6A5W338E,CAFFEINE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b2c6b352-f837-4903-8e4c-fb0a2b20bb60/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2c6b352-f837-4903-8e4c-fb0a2b20bb60,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2c6b352-f837-4903-8e4c-fb0a2b20bb60,b2c6b352-f837-4903-8e4c-fb0a2b20bb60
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,ANDA,77906,Caffeine Citrate,CAFFEINE CITRATE,20190522,Central Nervous System Stimulant; Methylxanthine,,AMERICAN REGENT INC,2007/09/10-,0517-0020,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d17e3be5-514f-454a-8347-d804cd5ec37f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d17e3be5-514f-454a-8347-d804cd5ec37f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d17e3be5-514f-454a-8347-d804cd5ec37f,d17e3be5-514f-454a-8347-d804cd5ec37f
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA,207400,CAFFEINE CITRATE,CAFFEINE CITRATE,20190304,Central Nervous System Stimulant; Methylxanthine,,MICRO LABS LIMITED,2017/12/30-,42571-244,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/279a43b8-9ff5-4792-ac19-441f3fa49269/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=279a43b8-9ff5-4792-ac19-441f3fa49269,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=279a43b8-9ff5-4792-ac19-441f3fa49269,279a43b8-9ff5-4792-ac19-441f3fa49269
HUMAN PRESCRIPTION DRUG LABEL,INJECTION; SOLUTION,INTRAVENOUS; ORAL,ANDA,090077;090357,Caffeine Citrate,CAFFEINE CITRATE,20190301,Central Nervous System Stimulant; Methylxanthine,,SUN PHARMACEUTICAL INDUSTRIES INC,2014/06/05-; completed:2014/06/02-2017/12/31,47335-289; 47335-290,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d06d3810-9923-4199-be5e-ee5ee086b0a4/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d06d3810-9923-4199-be5e-ee5ee086b0a4,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d06d3810-9923-4199-be5e-ee5ee086b0a4,d06d3810-9923-4199-be5e-ee5ee086b0a4
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,78002,Caffeine Citrate,CAFFEINE CITRATE,20190228,Central Nervous System Stimulant; Methylxanthine,,FRESENIUS KABI USA LLC,2009/11/19-,63323-406,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b4fb7c77-1e82-48b7-83c5-dd04ec7c5c4e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4fb7c77-1e82-48b7-83c5-dd04ec7c5c4e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b4fb7c77-1e82-48b7-83c5-dd04ec7c5c4e,b4fb7c77-1e82-48b7-83c5-dd04ec7c5c4e
HUMAN PRESCRIPTION DRUG LABEL,INJECTION; SOLUTION,INTRAVENOUS; ORAL,ANDA,090077;090357,Caffeine Citrate,CAFFEINE CITRATE,20190104,Central Nervous System Stimulant; Methylxanthine,,SUN PHARMACEUTICAL INDUSTRIES INC,2009/10/01-; completed:2009/10/01-2017/12/31,47335-289; 47335-290,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/cc632825-e0a4-4524-8d7d-ce926efab3d6/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc632825-e0a4-4524-8d7d-ce926efab3d6,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc632825-e0a4-4524-8d7d-ce926efab3d6,cc632825-e0a4-4524-8d7d-ce926efab3d6
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,20793,CAFCIT,CAFFEINE CITRATE,20181209,Central Nervous System Stimulant; Methylxanthine,,WEST WARD PHARMACEUTICALS CORP,2008/11/04-,0641-6164,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/21489401-f2a7-47d3-897a-4b7efa04dd7a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21489401-f2a7-47d3-897a-4b7efa04dd7a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21489401-f2a7-47d3-897a-4b7efa04dd7a,21489401-f2a7-47d3-897a-4b7efa04dd7a
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,ANDA,77997,Caffeine Citrate,CAFFEINE CITRATE,20180731,Central Nervous System Stimulant; Methylxanthine,,FRESENIUS KABI USA LLC,2009/11/19-,63323-407,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/baf9f88a-776a-44e7-82cc-8f0ca419572f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=baf9f88a-776a-44e7-82cc-8f0ca419572f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=baf9f88a-776a-44e7-82cc-8f0ca419572f,baf9f88a-776a-44e7-82cc-8f0ca419572f
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,ANDA,205013,Caffeine Citrate,CAFFEINE CITRATE,20171016,Central Nervous System Stimulant; Methylxanthine,,AUROMEDICS PHARMA LLC,2015/09/22-,55150-187,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8ef448ca-5549-4272-a6b4-5c4f57653c4c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ef448ca-5549-4272-a6b4-5c4f57653c4c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ef448ca-5549-4272-a6b4-5c4f57653c4c,8ef448ca-5549-4272-a6b4-5c4f57653c4c
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,ANDA,77997,Caffeine Citrate,CAFFEINE CITRATE,20170815,Central Nervous System Stimulant; Methylxanthine,,FRESENIUS KABI USA LLC,2009/11/19-,63323-407,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/38b39044-737a-4247-a6c4-c86f5e92490e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38b39044-737a-4247-a6c4-c86f5e92490e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=38b39044-737a-4247-a6c4-c86f5e92490e,38b39044-737a-4247-a6c4-c86f5e92490e
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,77304,caffeine citrate,CAFFEINE CITRATE,20150909,Central Nervous System Stimulant; Methylxanthine,,EXELA PHARMA SCIENCES LLC,2006/09/21-,51754-0503,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/bd6ac18d-c65c-42bc-a3ca-7a428c13aae7/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bd6ac18d-c65c-42bc-a3ca-7a428c13aae7,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bd6ac18d-c65c-42bc-a3ca-7a428c13aae7,bd6ac18d-c65c-42bc-a3ca-7a428c13aae7
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,ANDA,77233,caffeine citrate,CAFFEINE CITRATE,20150909,Central Nervous System Stimulant; Methylxanthine,,EXELA PHARMA SCIENCES LLC,2006/09/21-,51754-0502,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6de25a89-23b3-41e3-91aa-d86ca83686d4/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6de25a89-23b3-41e3-91aa-d86ca83686d4,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6de25a89-23b3-41e3-91aa-d86ca83686d4,6de25a89-23b3-41e3-91aa-d86ca83686d4
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,77304,caffeine citrate,CAFFEINE CITRATE,20150326,Central Nervous System Stimulant; Methylxanthine,,EXELA PHARMA SCIENCES LLC,2006/09/21-,51754-0501,U26EO4675Q,Caffeine Citrate,Caffeine,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/5d05ebf4-fd27-3bd1-5634-b41e33abc41f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d05ebf4-fd27-3bd1-5634-b41e33abc41f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d05ebf4-fd27-3bd1-5634-b41e33abc41f,5d05ebf4-fd27-3bd1-5634-b41e33abc41f
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,ANDA,77233,caffeine citrate,CAFFEINE CITRATE,20141201,Central Nervous System Stimulant; Methylxanthine,,EXELA PHARMA SCIENCES LLC,2006/09/21-,51754-0500,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f423a220-e7bf-4d24-bc52-bafc1864265b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f423a220-e7bf-4d24-bc52-bafc1864265b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f423a220-e7bf-4d24-bc52-bafc1864265b,f423a220-e7bf-4d24-bc52-bafc1864265b
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS; ORAL,ANDA,090827;091102,caffeine citrate,CAFFEINE CITRATE,20140915,Central Nervous System Stimulant; Methylxanthine,,SAGENT PHARMACEUTICALS,2012/09/15-,25021-601; 25021-602,U26EO4675Q,caffeine citrate,caffeine,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/5f38c395-0093-4afd-89ec-f96e5dc0934a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f38c395-0093-4afd-89ec-f96e5dc0934a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5f38c395-0093-4afd-89ec-f96e5dc0934a,5f38c395-0093-4afd-89ec-f96e5dc0934a
HUMAN PRESCRIPTION DRUG LABEL,INJECTION; SOLUTION,INTRAVENOUS; ORAL,ANDA,090077;090357,CAFFEINE CITRATE,CAFFEINE CITRATE,20091002,Central Nervous System Stimulant; Methylxanthine,,SUN PHARMACEUTICAL INDUSTRIES LTD,2009/10/01-,62756-289; 62756-290,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/dfa7e0a9-eac0-4741-9b85-69c122f13e33/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfa7e0a9-eac0-4741-9b85-69c122f13e33,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfa7e0a9-eac0-4741-9b85-69c122f13e33,dfa7e0a9-eac0-4741-9b85-69c122f13e33
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,20232,"BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE","CODEINE PHOSPHATE, BUTALBITAL, CAFFEINE, AND ACETAMINOPHEN CAPSULE",20091022,Barbiturate; Central Nervous System Stimulant; Methylxanthine,,PHYSICIANS TOTAL CARE INC,2009/07/06-,54868-5162,362O9ITL9D; 3G6A5W338E; GSL05Y1MN6; KHS0AZ4JVK,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE,ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE,362O9ITL9D; 3G6A5W338E; KHS0AZ4JVK; Q830PW7520,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/908bdfc3-ac28-44c9-aa59-39e7b9b28903/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=908bdfc3-ac28-44c9-aa59-39e7b9b28903,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=908bdfc3-ac28-44c9-aa59-39e7b9b28903,908bdfc3-ac28-44c9-aa59-39e7b9b28903
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,202842,Dexmethylphenidate Hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190624,Central Nervous System Stimulant,2001,PAR PHARMACEUTICAL INC,2017/01/05-,49884-048; 49884-049; 49884-090; 49884-248; 49884-333; 49884-339; 49884-539; 49884-546,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e304388e-86a6-4335-abae-0ce79c7c99c6/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e304388e-86a6-4335-abae-0ce79c7c99c6,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e304388e-86a6-4335-abae-0ce79c7c99c6,e304388e-86a6-4335-abae-0ce79c7c99c6
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,203614,Dexmethylphenidate hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190612,Central Nervous System Stimulant,2001,AMNEAL PHARMACEUTICALS OF NEW YORK LLC,2017/07/05-,0115-1709; 0115-1710,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/be7019d7-eb3e-48eb-b6ba-0ffefae6dcd0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be7019d7-eb3e-48eb-b6ba-0ffefae6dcd0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be7019d7-eb3e-48eb-b6ba-0ffefae6dcd0,be7019d7-eb3e-48eb-b6ba-0ffefae6dcd0
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,79108,Dexmethylphenidate hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190612,Central Nervous System Stimulant,2001,AMNEAL PHARMACEUTICALS OF NEW YORK LLC,2014/02/24-; 2014/11/11-; 2015/08/06-; 2015/12/21-,0115-9918; 0115-9919; 0115-9920; 0115-9921; 0115-9922,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/93e56455-0f15-4ed9-a63a-7fbd0697d520/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93e56455-0f15-4ed9-a63a-7fbd0697d520,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=93e56455-0f15-4ed9-a63a-7fbd0697d520,93e56455-0f15-4ed9-a63a-7fbd0697d520
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,78992,Dexmethylphenidate Hydrochloride Extended-Release,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190501,Central Nervous System Stimulant,2001,PAR PHARMACEUTICALS INC,2013/11/19-,49884-428; 49884-430,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4ed9f3c8-c71f-499e-bb91-c19847bf4444/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ed9f3c8-c71f-499e-bb91-c19847bf4444,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ed9f3c8-c71f-499e-bb91-c19847bf4444,4ed9f3c8-c71f-499e-bb91-c19847bf4444
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,207901,Dexmethylphenidate Hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190319,Central Nervous System Stimulant,2001,TRIS PHARMA INC,2001/11/30-,27808-091; 27808-092; 27808-093,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1f2aa66a-51dc-459c-a765-5364bccd310f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f2aa66a-51dc-459c-a765-5364bccd310f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1f2aa66a-51dc-459c-a765-5364bccd310f,1f2aa66a-51dc-459c-a765-5364bccd310f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,201231,Dexmethylphenidate hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190226,Central Nervous System Stimulant,2001,SUN PHARMACEUTICAL INDUSTRIES INC,2013/09/26-,57664-376; 57664-378; 57664-379,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/987b4983-1edc-40f1-adc9-724747080969/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=987b4983-1edc-40f1-adc9-724747080969,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=987b4983-1edc-40f1-adc9-724747080969,987b4983-1edc-40f1-adc9-724747080969
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,202580;204266,Dexmethylphenidate Hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190215,Central Nervous System Stimulant,2001,MYLAN PHARMACEUTICALS INC,2013/11/18-; 2015/08/26-; 2015/12/21-,0378-4080; 0378-4081; 0378-4082; 0378-4083; 0378-4084; 0378-4085,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a30ac4c6-5178-4378-a211-a6dd8b1fbc59/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a30ac4c6-5178-4378-a211-a6dd8b1fbc59,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a30ac4c6-5178-4378-a211-a6dd8b1fbc59,a30ac4c6-5178-4378-a211-a6dd8b1fbc59
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,208756,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190208,Central Nervous System Stimulant,2001,RHODES PHARMACEUTICALS L P,2017/12/01-,42858-011; 42858-225; 42858-410,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/01362bb1-7a95-4b79-b52f-69f68ac13915/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01362bb1-7a95-4b79-b52f-69f68ac13915,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=01362bb1-7a95-4b79-b52f-69f68ac13915,01362bb1-7a95-4b79-b52f-69f68ac13915
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,21802,Focalin XR,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190131,Central Nervous System Stimulant,2005,NOVARTIS PHARMACEUTICALS CORPORATION,2005/05/31-,0078-0430; 0078-0431; 0078-0432; 0078-0433; 0078-0434; 0078-0493; 0078-0608; 0078-0609,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1a1da905-42a0-4748-9c39-67eca45deccc/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a1da905-42a0-4748-9c39-67eca45deccc,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a1da905-42a0-4748-9c39-67eca45deccc,1a1da905-42a0-4748-9c39-67eca45deccc
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,21278,Focalin,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190131,Central Nervous System Stimulant,2001,NOVARTIS PHARMACEUTICALS CORPORATION,2001/11/30-,0078-0380; 0078-0381; 0078-0382,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/7c552f11-e24a-4d9b-bb8d-be10c928eca8/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c552f11-e24a-4d9b-bb8d-be10c928eca8,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7c552f11-e24a-4d9b-bb8d-be10c928eca8,7c552f11-e24a-4d9b-bb8d-be10c928eca8
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,078908;202731,Dexmethylphenidate Hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190125,Central Nervous System Stimulant,2001,TEVA PHARMACEUTICALS USA INC,2013/11/21-; 2014/05/21-; 2014/05/22-; 2014/11/10-; 2015/02/02-,0093-5045; 0093-5046; 0093-5550; 0093-5551; 0093-5552; 0093-5553; 0093-5554; 0093-5562,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/dd659d39-41f5-4612-8f17-bad602b4784d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd659d39-41f5-4612-8f17-bad602b4784d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd659d39-41f5-4612-8f17-bad602b4784d,dd659d39-41f5-4612-8f17-bad602b4784d
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21802,Dexmethylphenidate Hydrochloride Extended-Release,DEXMETHYLPHENIDATE HYDROCHLORIDE,20190117,Central Nervous System Stimulant,2005,SANDOZ INC,2014/01/02-; 2014/01/28-; 2014/03/04-; 2014/11/12-; 2015/02/03-,0781-2682; 0781-2683; 0781-2684; 0781-2685; 0781-2686; 0781-2687; 0781-2688; 0781-2689,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/77342716-6dd7-488d-bfa4-9637feb4b5f0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=77342716-6dd7-488d-bfa4-9637feb4b5f0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=77342716-6dd7-488d-bfa4-9637feb4b5f0,77342716-6dd7-488d-bfa4-9637feb4b5f0
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,206931,Dexmethylphenidate Hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20181219,Central Nervous System Stimulant,,KVK TECH INC,2015/12/04-,10702-106; 10702-107; 10702-108,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/0c717ae4-ec27-47db-ac1b-e504dbb379be/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c717ae4-ec27-47db-ac1b-e504dbb379be,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c717ae4-ec27-47db-ac1b-e504dbb379be,0c717ae4-ec27-47db-ac1b-e504dbb379be
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA authorized generic,21278,Dexmethylphenidate Hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20181129,Central Nervous System Stimulant,,SANDOZ INC,2015/04/27-,0781-5676; 0781-5689; 0781-5691,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/07efe5d5-9857-490a-9a31-9dd07ea9386e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07efe5d5-9857-490a-9a31-9dd07ea9386e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=07efe5d5-9857-490a-9a31-9dd07ea9386e,07efe5d5-9857-490a-9a31-9dd07ea9386e
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,204534,Dexmethylphenidate Hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20171017,Central Nervous System Stimulant,,LUPIN PHARMACEUTICALS INC,2015/12/04-,43386-860; 43386-861; 43386-862,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a61932ef-c2b6-4363-a21d-1f0358f317b6/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a61932ef-c2b6-4363-a21d-1f0358f317b6,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a61932ef-c2b6-4363-a21d-1f0358f317b6,a61932ef-c2b6-4363-a21d-1f0358f317b6
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,79108,Dexmethylphenidate hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20170131,Central Nervous System Stimulant,2005,IMPAX GENERICS,2014/02/24-; 2014/11/11-; 2015/08/06-; 2015/12/21-,0115-1682; 0115-1683; 0115-1684; 0115-1685; 0115-1686,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/5312f2c3-bd73-4d29-b8d1-e989282be750/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5312f2c3-bd73-4d29-b8d1-e989282be750,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5312f2c3-bd73-4d29-b8d1-e989282be750,5312f2c3-bd73-4d29-b8d1-e989282be750
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,77107,Dexmethylphenidate Hydrochloride,DEXMETHYLPHENIDATE HYDROCHLORIDE,20170101,Central Nervous System Stimulant,,TEVA PHARMACEUTICALS USA INC,completed:2007/06/08-2020/05/31; completed:2007/06/08-2020/06/30,0093-5275; 0093-5276; 0093-5277,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d334e2f1-7497-4131-a5c0-7ac30d4741cb/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d334e2f1-7497-4131-a5c0-7ac30d4741cb,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d334e2f1-7497-4131-a5c0-7ac30d4741cb,d334e2f1-7497-4131-a5c0-7ac30d4741cb
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21802,Dexmethylphenidate Hydrochloride Extended-Release,DEXMETHYLPHENIDATE HYDROCHLORIDE,20151223,Central Nervous System Stimulant,2005,AVERA MCKENNAN HOSPITAL,2015/12/01-,69189-2685,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c72a641c-6846-4df9-8ff0-fa8036d6ac27/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c72a641c-6846-4df9-8ff0-fa8036d6ac27,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c72a641c-6846-4df9-8ff0-fa8036d6ac27,c72a641c-6846-4df9-8ff0-fa8036d6ac27
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,21802,FOCALIN XR,DEXMETHYLPHENIDATE HYDROCHLORIDE,20110613,Central Nervous System Stimulant,2005,STAT RX USA LLC,2005/05/31-,16590-649,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/bdb43b40-d34d-47f0-b522-a0ad2d2b1185/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bdb43b40-d34d-47f0-b522-a0ad2d2b1185,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bdb43b40-d34d-47f0-b522-a0ad2d2b1185,bdb43b40-d34d-47f0-b522-a0ad2d2b1185
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,21802,FocalinXR,DEXMETHYLPHENIDATE HYDROCHLORIDE,20101111,Central Nervous System Stimulant,2005,PHYSICIANS TOTAL CARE INC,2006/10/11-,54868-5681; 54868-5682; 54868-5683; 54868-5684,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/00f1d83e-93cc-4bbe-9c3b-c488062271ab/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00f1d83e-93cc-4bbe-9c3b-c488062271ab,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00f1d83e-93cc-4bbe-9c3b-c488062271ab,00f1d83e-93cc-4bbe-9c3b-c488062271ab
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,203644,Dextroamphetamine,DEXTROAMPHETAMINE,20190522,Central Nervous System Stimulant,,TRIS PHARMA INC,2013/05/31-,27808-085,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/7658071e-ee2c-4d23-94ce-1906959ec036/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7658071e-ee2c-4d23-94ce-1906959ec036,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7658071e-ee2c-4d23-94ce-1906959ec036,7658071e-ee2c-4d23-94ce-1906959ec036
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40440,Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate,DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE,20180124,Central Nervous System Stimulant,,SPECGX LLC,2010/02/18-,0406-8884; 0406-8885; 0406-8891; 0406-8892; 0406-8893; 0406-8894,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/72ddd1c9-ddbd-4c95-acd9-003189a353a3/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72ddd1c9-ddbd-4c95-acd9-003189a353a3,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72ddd1c9-ddbd-4c95-acd9-003189a353a3,72ddd1c9-ddbd-4c95-acd9-003189a353a3
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40439,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20181012,Central Nervous System Stimulant,,EON LABS INC,2016/04/20-,0185-0831; 0185-0842; 0185-0853; 0185-0864,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/288dafc4-fe6e-4891-832f-511022c87445/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=288dafc4-fe6e-4891-832f-511022c87445,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=288dafc4-fe6e-4891-832f-511022c87445,288dafc4-fe6e-4891-832f-511022c87445
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40440,"Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20130709,Central Nervous System Stimulant,,PHYSICIANS TOTAL CARE INC,2002/06/04-; 2003/01/17-; 2003/07/25-; 2004/07/07-; 2005/08/11-,54868-4631; 54868-4728; 54868-4863; 54868-5103; 54868-5387,6DPV8NK46S; G83415V073; H527KAP6L5; JJ768O327N,AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d63a086a-32e2-49e2-949e-64e4c922775a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d63a086a-32e2-49e2-949e-64e4c922775a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d63a086a-32e2-49e2-949e-64e4c922775a,d63a086a-32e2-49e2-949e-64e4c922775a
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,77302,"Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE",20170831,Central Nervous System Stimulant,2001,ACTAVIS PHARMA INC,2012/06/22-,0228-3059; 0228-3060; 0228-3061; 0228-3062; 0228-3063; 0228-3064,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c5c2d060-452c-4f76-ad93-2e41fd8f06c2/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5c2d060-452c-4f76-ad93-2e41fd8f06c2,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5c2d060-452c-4f76-ad93-2e41fd8f06c2,c5c2d060-452c-4f76-ad93-2e41fd8f06c2
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,76852,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20190613,Central Nervous System Stimulant,2001,AMNEAL PHARMACEUTICALS OF NEW YORK LLC,2016/02/16-,0115-1486; 0115-1487; 0115-1488; 0115-1489; 0115-1490; 0115-1491,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/89c4b21a-1a65-41ef-8718-1619c2ba8591/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89c4b21a-1a65-41ef-8718-1619c2ba8591,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89c4b21a-1a65-41ef-8718-1619c2ba8591,89c4b21a-1a65-41ef-8718-1619c2ba8591
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21303,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20190416,Central Nervous System Stimulant,2001,SANDOZ INC,2009/04/02-,0781-2329; 0781-2335; 0781-2343; 0781-2352; 0781-2368; 0781-2371,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6f637e8d-7c2e-47fa-a43c-3250c51aed77/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f637e8d-7c2e-47fa-a43c-3250c51aed77,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f637e8d-7c2e-47fa-a43c-3250c51aed77,6f637e8d-7c2e-47fa-a43c-3250c51aed77
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21303,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20181127,Central Nervous System Stimulant,2001,PRASCO LABORATORIES,2009/04/02-,66993-594; 66993-595; 66993-596; 66993-597; 66993-598; 66993-599,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f85af6ee-9029-42de-adea-6dbb8642952c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f85af6ee-9029-42de-adea-6dbb8642952c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f85af6ee-9029-42de-adea-6dbb8642952c,f85af6ee-9029-42de-adea-6dbb8642952c
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40422,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SUFLATE","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SUFLATE",20100625,Central Nervous System Stimulant,,STAT RX USA LLC,2009/12/18-,16590-901,6DPV8NK46S; G83415V073; H527KAP6L5; JJ768O327N,AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f55aba1f-9404-4a49-8e3b-7a66ce538c60/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f55aba1f-9404-4a49-8e3b-7a66ce538c60,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f55aba1f-9404-4a49-8e3b-7a66ce538c60,f55aba1f-9404-4a49-8e3b-7a66ce538c60
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40422,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20190817,Central Nervous System Stimulant,,BRYANT RANCH PREPACK,2002/02/11-,63629-3730; 63629-7487,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6670decb-e6bb-462e-9cec-cd70fde20b58/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6670decb-e6bb-462e-9cec-cd70fde20b58,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6670decb-e6bb-462e-9cec-cd70fde20b58,6670decb-e6bb-462e-9cec-cd70fde20b58
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,202424,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20190204,Central Nervous System Stimulant,,AUROLIFE PHARMA LLC,2013/11/27-,13107-068; 13107-069; 13107-070; 13107-071; 13107-072; 13107-073; 13107-074,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a582d57f-d191-4ca5-b105-585b2d8a0e3e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a582d57f-d191-4ca5-b105-585b2d8a0e3e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a582d57f-d191-4ca5-b105-585b2d8a0e3e,a582d57f-d191-4ca5-b105-585b2d8a0e3e
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,202424,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20190107,Central Nervous System Stimulant,,ACETRIS HEALTH LLC,2017/11/27-,52343-160; 52343-161; 52343-162; 52343-163; 52343-164; 52343-165; 52343-166,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/7a72e13a-33b1-48f2-b036-7e08cb7b65ff/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a72e13a-33b1-48f2-b036-7e08cb7b65ff,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7a72e13a-33b1-48f2-b036-7e08cb7b65ff,7a72e13a-33b1-48f2-b036-7e08cb7b65ff
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,207340,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20181231,Central Nervous System Stimulant,,ZYDUS PHARMACEUTICALS USA INC,2017/10/31-,68382-950; 68382-951; 68382-952; 68382-953; 68382-954; 68382-955; 68382-956,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6bf5bcd5-bed6-4405-a61d-af593b4a3a43/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6bf5bcd5-bed6-4405-a61d-af593b4a3a43,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6bf5bcd5-bed6-4405-a61d-af593b4a3a43,6bf5bcd5-bed6-4405-a61d-af593b4a3a43
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40444,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20181204,Central Nervous System Stimulant,,COREPHARMA LLC,completed:2007/05/09-2019/11/01; completed:2007/05/09-2020/01/01; completed:2007/05/09-2020/02/01; completed:2014/11/07-2018/03/01; completed:2014/11/07-2018/11/01,64720-130; 64720-131; 64720-132; 64720-133; 64720-134; 64720-135; 64720-136,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4cc84b5d-9b56-4b80-a201-6e4075727d44/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cc84b5d-9b56-4b80-a201-6e4075727d44,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4cc84b5d-9b56-4b80-a201-6e4075727d44,4cc84b5d-9b56-4b80-a201-6e4075727d44
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40444,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20180101,Central Nervous System Stimulant,,BRYANT RANCH PREPACK,2007/05/09-,71335-0178,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6e15d882-4db2-4f24-b9b5-45af630cb40b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e15d882-4db2-4f24-b9b5-45af630cb40b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6e15d882-4db2-4f24-b9b5-45af630cb40b,6e15d882-4db2-4f24-b9b5-45af630cb40b
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40422,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Suflate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20170917,Central Nervous System Stimulant,,BRYANT RANCH PREPACK,2002/02/11-,63629-3731,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1714de28-482e-463f-e91f-eeaaaa83d17f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1714de28-482e-463f-e91f-eeaaaa83d17f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1714de28-482e-463f-e91f-eeaaaa83d17f,1714de28-482e-463f-e91f-eeaaaa83d17f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40422,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20160901,Central Nervous System Stimulant,,TEVA PHARMACEUTICALS USA INC,2002/02/11-; 2003/03/19-,0555-0775; 0555-0776; 0555-0777; 0555-0971; 0555-0972; 0555-0973; 0555-0974,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/cffbbb15-d776-41ae-a8a6-687f2c07bfa4/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cffbbb15-d776-41ae-a8a6-687f2c07bfa4,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cffbbb15-d776-41ae-a8a6-687f2c07bfa4,cffbbb15-d776-41ae-a8a6-687f2c07bfa4
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21303,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20150512,Central Nervous System Stimulant,2001,GLOBAL PHARMACEUTICALS DIVISION OF IMPAX LABORATORIES INC,2013/12/17-,0115-1328; 0115-1329; 0115-1330; 0115-1331; 0115-1332; 0115-1333,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/34726042-2386-4c19-abec-440769fff99a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34726042-2386-4c19-abec-440769fff99a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=34726042-2386-4c19-abec-440769fff99a,34726042-2386-4c19-abec-440769fff99a
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21303,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",20100518,Central Nervous System Stimulant,,PHYSICIANS TOTAL CARE INC,2009/05/04-; 2009/05/19-; 2010/11/01-; 2011/03/03-,54868-6028; 54868-6029; 54868-6033; 54868-6034; 54868-6192; 54868-6227,6DPV8NK46S; G83415V073; H527KAP6L5; JJ768O327N,AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f6c30ba1-53d0-4f85-a515-81acfb922e73/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6c30ba1-53d0-4f85-a515-81acfb922e73,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f6c30ba1-53d0-4f85-a515-81acfb922e73,f6c30ba1-53d0-4f85-a515-81acfb922e73
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,207388,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 10 MG,CLL; DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 12.5 MG,CLL; DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 15 MG,CLL; DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 20 MG,CLL; DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 30 MG,CLL; DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 5 MG,CLL; DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 7.5 MG,CLL",20190717,Central Nervous System Stimulant,,ALVOGEN INC,2017/07/28-; completed:2017/07/28-2017/07/29,47781-174; 47781-175; 47781-176; 47781-177; 47781-178; 47781-179; 47781-180,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE SULFATE; Amphetamine Aspartate Monohydrate; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c907301d-e24d-9609-5529-fed14f94549f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c907301d-e24d-9609-5529-fed14f94549f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c907301d-e24d-9609-5529-fed14f94549f,c907301d-e24d-9609-5529-fed14f94549f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40480,"Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20180313,Central Nervous System Stimulant,,BRYANT RANCH PREPACK,2003/09/09-,71335-0171; 71335-0198,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b90efc87-f328-4501-b7bb-d059ac501f7f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90efc87-f328-4501-b7bb-d059ac501f7f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b90efc87-f328-4501-b7bb-d059ac501f7f,b90efc87-f328-4501-b7bb-d059ac501f7f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40480,"Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20171226,Central Nervous System Stimulant,,SUN PHARMACEUTICAL INDUSTRIES INC,2003/09/09-,57664-641; 57664-642; 57664-643; 57664-644; 57664-645; 57664-646; 57664-647,6DPV8NK46S; G83415V073; H527KAP6L5; JJ768O327N,Amphetamine aspartate; Amphetamine sulfate; Dextroamphetamine saccharate; Dextroamphetamine sulfate,Amphetamine; Dextroamphetamine,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9af67219-9b37-45d0-ac52-647cbfacd296/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9af67219-9b37-45d0-ac52-647cbfacd296,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9af67219-9b37-45d0-ac52-647cbfacd296,9af67219-9b37-45d0-ac52-647cbfacd296
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40422,Adderall,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20160901,Central Nervous System Stimulant,,TEVA SELECT BRANDS,2014/02/03-; 2014/02/06-; 2014/02/11-; 2014/06/18-; 2014/06/30-,57844-105; 57844-110; 57844-112; 57844-115; 57844-117; 57844-120; 57844-130,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f22635fe-821d-4cde-aa12-419f8b53db81/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f22635fe-821d-4cde-aa12-419f8b53db81,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f22635fe-821d-4cde-aa12-419f8b53db81,f22635fe-821d-4cde-aa12-419f8b53db81
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21303,"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate","DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20160628,Central Nervous System Stimulant,2001,BARR LABORATORIES INC,2009/04/02-,0555-0787; 0555-0788; 0555-0789; 0555-0790; 0555-0791; 0555-0792,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a200fc5e-faab-4471-af77-64da407fa131/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a200fc5e-faab-4471-af77-64da407fa131,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a200fc5e-faab-4471-af77-64da407fa131,a200fc5e-faab-4471-af77-64da407fa131
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40422,Adderall,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20121023,Central Nervous System Stimulant,,BRYANT RANCH PREPACK,1996/02/13-,63629-3768,6DPV8NK46S; G83415V073; H527KAP6L5; JJ768O327N,AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/49b7d111-7045-4116-8988-ba93c7d63491/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49b7d111-7045-4116-8988-ba93c7d63491,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49b7d111-7045-4116-8988-ba93c7d63491,49b7d111-7045-4116-8988-ba93c7d63491
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40422,Adderall,"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",20121023,Central Nervous System Stimulant,,BRYANT RANCH PREPACK,1996/02/13-,63629-3769,6DPV8NK46S; G83415V073; H527KAP6L5; JJ768O327N,AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b6c8d902-4d43-46b0-b96c-00d8bed1b3dd/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6c8d902-4d43-46b0-b96c-00d8bed1b3dd,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b6c8d902-4d43-46b0-b96c-00d8bed1b3dd,b6c8d902-4d43-46b0-b96c-00d8bed1b3dd
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,202893,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE SULFATE,20190911,Central Nervous System Stimulant,,AUROLIFE PHARMA LLC,2013/07/31-,13107-035; 13107-036,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/24163442-dd03-4066-a6ed-eb7e292b700b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24163442-dd03-4066-a6ed-eb7e292b700b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24163442-dd03-4066-a6ed-eb7e292b700b,24163442-dd03-4066-a6ed-eb7e292b700b
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,40776,dextroamphetamine sulfate,DEXTROAMPHETAMINE SULFATE,20190904,Central Nervous System Stimulant,,AVADEL GENERICS LLC,completed:2014/01/06-2020/09/30,76181-002,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f56ea6e8-265a-4e2c-a489-2ad8a50d3157/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f56ea6e8-265a-4e2c-a489-2ad8a50d3157,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f56ea6e8-265a-4e2c-a489-2ad8a50d3157,f56ea6e8-265a-4e2c-a489-2ad8a50d3157
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,40776,Procentra,DEXTROAMPHETAMINE SULFATE,20190904,Central Nervous System Stimulant,,INDEPENDENCE PHARMACEUTICALS LLC,2014/05/15-,21724-701,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1548cce2-fb6b-4f17-8a3b-868933f6c9d6/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1548cce2-fb6b-4f17-8a3b-868933f6c9d6,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1548cce2-fb6b-4f17-8a3b-868933f6c9d6,1548cce2-fb6b-4f17-8a3b-868933f6c9d6
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,90533,Zenzedi,DEXTROAMPHETAMINE SULFATE,20190814,Central Nervous System Stimulant,,ARBOR PHARMACEUTICALS INC,2013/05/31-; 2014/05/01-,24338-850; 24338-851; 24338-852; 24338-853; 24338-854; 24338-855; 24338-856,JJ768O327N,Dextroamphetamine Sulfate,Dextroamphetamine,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d6394df5-f2c9-47eb-b57e-f3e9cfd94f84/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6394df5-f2c9-47eb-b57e-f3e9cfd94f84,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d6394df5-f2c9-47eb-b57e-f3e9cfd94f84,d6394df5-f2c9-47eb-b57e-f3e9cfd94f84
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,203901,dextroamphetamine sulfate,DEXTROAMPHETAMINE SULFATE,20190508,Central Nervous System Stimulant,,ACTAVIS PHARMA INC,2014/06/19-,45963-303; 45963-304; 45963-305,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9e92ccc3-d81c-461d-a19f-7e9b582be357/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e92ccc3-d81c-461d-a19f-7e9b582be357,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e92ccc3-d81c-461d-a19f-7e9b582be357,9e92ccc3-d81c-461d-a19f-7e9b582be357
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,76353,Dextroamphetamine Sulfate Extended-Release,DEXTROAMPHETAMINE SULFATE,20190412,Central Nervous System Stimulant,,AMERICAN HEALTH PACKAGING,completed:2015/09/29-2020/04/30,60687-150,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/669a308e-ce09-4ac8-84d9-ee252c5d3223/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=669a308e-ce09-4ac8-84d9-ee252c5d3223,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=669a308e-ce09-4ac8-84d9-ee252c5d3223,669a308e-ce09-4ac8-84d9-ee252c5d3223
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,203901,dextroamphetamine sulfate,DEXTROAMPHETAMINE SULFATE,20190329,Central Nervous System Stimulant,,MAYNE PHARMA INC,2016/08/05-,51862-344; 51862-345; 51862-346,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/448c2930-3a4e-4e29-9269-a343991d2877/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=448c2930-3a4e-4e29-9269-a343991d2877,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=448c2930-3a4e-4e29-9269-a343991d2877,448c2930-3a4e-4e29-9269-a343991d2877
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,206588,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE SULFATE,20181231,Central Nervous System Stimulant,,ZYDUS PHARMACEUTICALS USA INC,2016/03/28-,68382-941; 68382-942,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/0d50f495-f1e0-4231-b0c3-6ebb7ad68f4e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d50f495-f1e0-4231-b0c3-6ebb7ad68f4e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0d50f495-f1e0-4231-b0c3-6ebb7ad68f4e,0d50f495-f1e0-4231-b0c3-6ebb7ad68f4e
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,203548,Dextroamphetamine Sulfate,DEXTROAMPHETAMINE SULFATE,20181219,Central Nervous System Stimulant,,KVK TECH INC,2015/11/23-,10702-065; 10702-066,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/863d66fe-9c38-463a-afa1-552647494c5a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=863d66fe-9c38-463a-afa1-552647494c5a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=863d66fe-9c38-463a-afa1-552647494c5a,863d66fe-9c38-463a-afa1-552647494c5a
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,17078,Dextroamphetamine Sulfate Extended-Release,DEXTROAMPHETAMINE SULFATE,20181207,Central Nervous System Stimulant,,LINEAGE THERAPEUTICS INC,completed:1976/08/02-2019/11/01; completed:1976/08/02-2019/12/01,54505-327; 54505-328; 54505-329,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6ca9dd45-08f8-11e3-8ffd-0800200c9a66/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ca9dd45-08f8-11e3-8ffd-0800200c9a66,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ca9dd45-08f8-11e3-8ffd-0800200c9a66,6ca9dd45-08f8-11e3-8ffd-0800200c9a66
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,17078,DEXEDRINE SPANSULE,DEXTROAMPHETAMINE SULFATE,20181207,Central Nervous System Stimulant,,AMEDRA PHARMACEUTICALS LLC,completed:1976/08/02-2019/12/01,52054-512; 52054-513; 52054-514,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a37b6ef9-78b4-4b18-8797-ecb583502500/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a37b6ef9-78b4-4b18-8797-ecb583502500,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a37b6ef9-78b4-4b18-8797-ecb583502500,a37b6ef9-78b4-4b18-8797-ecb583502500
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,90533,Dextroamphetamine Sulfate,DEXTROAMPHETAMINE SULFATE,20181203,Central Nervous System Stimulant,,WILSHIRE PHARMACEUTICALS INC,2012/07/16-; 2012/07/20-,52536-500; 52536-510,JJ768O327N,Dextroamphetamine Sulfate,Dextroamphetamine,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6b8c97ac-c83c-4a1f-a33c-121239253abf/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b8c97ac-c83c-4a1f-a33c-121239253abf,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6b8c97ac-c83c-4a1f-a33c-121239253abf,6b8c97ac-c83c-4a1f-a33c-121239253abf
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,76353,Dextroamphetamine Sulfate Extended-Release,DEXTROAMPHETAMINE SULFATE,20180119,Central Nervous System Stimulant,,SPECGX LLC,2011/10/07-,0406-8960; 0406-8961; 0406-8962,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/69c40af8-3710-46bf-bd3d-137fe5eea23e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69c40af8-3710-46bf-bd3d-137fe5eea23e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=69c40af8-3710-46bf-bd3d-137fe5eea23e,69c40af8-3710-46bf-bd3d-137fe5eea23e
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40436,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE SULFATE,20180119,Central Nervous System Stimulant,,SPECGX LLC,2010/02/05-,0406-8958; 0406-8959,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e05cf690-d45a-4696-a1bf-40c9350cc084/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e05cf690-d45a-4696-a1bf-40c9350cc084,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e05cf690-d45a-4696-a1bf-40c9350cc084,e05cf690-d45a-4696-a1bf-40c9350cc084
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,204330,Dextroamphetamine Sulfate,DEXTROAMPHETAMINE SULFATE,20171222,Central Nervous System Stimulant,,NOVEL LABORATORIES INC,2016/03/16-,40032-870; 40032-871,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9f0426b4-ecf2-4345-b1cf-c5f48832126b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f0426b4-ecf2-4345-b1cf-c5f48832126b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f0426b4-ecf2-4345-b1cf-c5f48832126b,9f0426b4-ecf2-4345-b1cf-c5f48832126b
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,17078,Dextroamphetamine SulfateExtended-Release Extended-Release,DEXTROAMPHETAMINE SULFATE,20170925,Central Nervous System Stimulant,,IMPAX GENERICS,1976/08/02-,0115-1702; 0115-1703; 0115-1704,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/36fa0ccd-33aa-4a22-8441-5f55f8d0870c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36fa0ccd-33aa-4a22-8441-5f55f8d0870c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=36fa0ccd-33aa-4a22-8441-5f55f8d0870c,36fa0ccd-33aa-4a22-8441-5f55f8d0870c
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,209111,Dextroamphetamine Sulfate,DEXTROAMPHETAMINE SULFATE,20170919,Central Nervous System Stimulant,,ZYDUS PHARMACEUTICALS USA INC,2017/06/28-,68382-943; 68382-944; 68382-945,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/124c91d5-b533-4caa-aa14-81f1dba9fa90/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=124c91d5-b533-4caa-aa14-81f1dba9fa90,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=124c91d5-b533-4caa-aa14-81f1dba9fa90,124c91d5-b533-4caa-aa14-81f1dba9fa90
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,204330,Dextroamphetamine Sulfate,DEXTROAMPHETAMINE SULFATE,20170605,Central Nervous System Stimulant,,LUPIN PHARMACEUTICALS INC,2016/04/25-,43386-870; 43386-871,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9aea6b7c-729c-484d-b625-c3591b63b350/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9aea6b7c-729c-484d-b625-c3591b63b350,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9aea6b7c-729c-484d-b625-c3591b63b350,9aea6b7c-729c-484d-b625-c3591b63b350
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,40776,dextroamphetamine sulfate,DEXTROAMPHETAMINE SULFATE,20161005,Central Nervous System Stimulant,,MIKART INC,2008/01/29-,46672-646,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b2fa8299-a9c0-436d-aae0-8c3e44b294a2/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2fa8299-a9c0-436d-aae0-8c3e44b294a2,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2fa8299-a9c0-436d-aae0-8c3e44b294a2,b2fa8299-a9c0-436d-aae0-8c3e44b294a2
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40361,Dextroamphetamine Sulfate,DEXTROAMPHETAMINE SULFATE,20160901,Central Nervous System Stimulant,,TEVA PHARMACEUTICALS USA INC,2001/02/12-,0555-0952; 0555-0953,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ec2d13f3-d14f-47e4-abe9-7763f95a8e94/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec2d13f3-d14f-47e4-abe9-7763f95a8e94,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ec2d13f3-d14f-47e4-abe9-7763f95a8e94,ec2d13f3-d14f-47e4-abe9-7763f95a8e94
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,76137,Dextroamphetamine Sulfate,DEXTROAMPHETAMINE SULFATE,20101118,Central Nervous System Stimulant,,PHYSICIANS TOTAL CARE INC,2005/08/15-; 2005/11/30-,54868-5388; 54868-5479,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/421cf8e0-ef59-4a19-9d1c-e1ec6596f32b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=421cf8e0-ef59-4a19-9d1c-e1ec6596f32b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=421cf8e0-ef59-4a19-9d1c-e1ec6596f32b,421cf8e0-ef59-4a19-9d1c-e1ec6596f32b
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,ANDA,40776,ProCentra,DEXTROAMPHETAMINE SULFATE,20100630,Central Nervous System Stimulant,,FSC LABORATORIES INC,2010/08/01-,13551-701,JJ768O327N,dextroamphetamine sulfate,dextroamphetamine,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/5bc88dc0-b6b2-4c3f-8ecb-03e41b085e1d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bc88dc0-b6b2-4c3f-8ecb-03e41b085e1d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5bc88dc0-b6b2-4c3f-8ecb-03e41b085e1d,5bc88dc0-b6b2-4c3f-8ecb-03e41b085e1d
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,040365;040367,dextroamphetamine sulfate,DEXTROAMPHETAMINE SULFATE,20070407,Central Nervous System Stimulant,,ETHEX CORPORATION,2009/11/01-,58177-311; 58177-312,JJ768O327N,dextroamphetamine sulfate,dextroamphetamine,TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b2ad8d2b-ed94-43cd-95ea-85e91d997f26/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2ad8d2b-ed94-43cd-95ea-85e91d997f26,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2ad8d2b-ed94-43cd-95ea-85e91d997f26,b2ad8d2b-ed94-43cd-95ea-85e91d997f26
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,22063,MYDAYIS,"DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE",20180813,Central Nervous System Stimulant,2001,SHIRE US MANUFACTURING INC,2017/06/20-,54092-468; 54092-471; 54092-474; 54092-477,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/141a7970-3f06-44ea-9ab7-aeece2c085fc/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=141a7970-3f06-44ea-9ab7-aeece2c085fc,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=141a7970-3f06-44ea-9ab7-aeece2c085fc,141a7970-3f06-44ea-9ab7-aeece2c085fc
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,21303,Adderall XR,"DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE",20190717,Central Nervous System Stimulant,2001,SHIRE US MANUFACTURING INC,2001/10/11-; 2002/05/22-,54092-381; 54092-383; 54092-385; 54092-387; 54092-389; 54092-391,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/aff45863-ffe1-4d4f-8acf-c7081512a6c0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aff45863-ffe1-4d4f-8acf-c7081512a6c0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aff45863-ffe1-4d4f-8acf-c7081512a6c0,aff45863-ffe1-4d4f-8acf-c7081512a6c0
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,21303,Adderall XR,"DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE",20120925,Central Nervous System Stimulant,2001,PHYSICIANS TOTAL CARE INC,2002/07/26-; 2003/03/20-; 2004/08/16-; 2004/08/23-; 2005/03/01-,54868-4640; 54868-4760; 54868-5007; 54868-5140; 54868-5142; 54868-5368,6DPV8NK46S; G83415V073; H527KAP6L5; JJ768O327N,AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/35744538-1704-4ee0-954d-52710cf3456d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35744538-1704-4ee0-954d-52710cf3456d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=35744538-1704-4ee0-954d-52710cf3456d,35744538-1704-4ee0-954d-52710cf3456d
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,206721,"Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate","DEXTROAMPHETAMINE, AMPHETAMINE, DEXTROAMPHETAMINE, AMPHETAMINE",20150508,Central Nervous System Stimulant,,MYLAN PHARMACEUTICALS INC,2015/11/10-,0378-4541; 0378-4542; 0378-4543; 0378-4544; 0378-4545; 0378-4546; 0378-4547,6DPV8NK46S; G83415V073; H527KAP6L5; JJ768O327N,AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/49289133-6071-406e-8b18-73a6e4db8782/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49289133-6071-406e-8b18-73a6e4db8782,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49289133-6071-406e-8b18-73a6e4db8782,49289133-6071-406e-8b18-73a6e4db8782
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40701,"Dihydrocodeine Bitartrate, Acetaminophen and Caffeine","DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN AND CAFFEINE",20091124,Central Nervous System Stimulant; Methylxanthine; Opioid Agonist,,PHYSICIANS TOTAL CARE INC,2008/05/20-,54868-5900,362O9ITL9D; 3G6A5W338E; 8LXS95BSA9,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE,ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE,362O9ITL9D; 3G6A5W338E; N9I9HDB855,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f3ddb645-028a-4c54-96b9-dbfecacf19bb/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3ddb645-028a-4c54-96b9-dbfecacf19bb,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f3ddb645-028a-4c54-96b9-dbfecacf19bb,f3ddb645-028a-4c54-96b9-dbfecacf19bb
HUMAN PRESCRIPTION DRUG LABEL,SUPPOSITORY,RECTAL,ANDA,86557,MIGERGOT,ERGOTAMINE TARTRATE AND CAFFEINE,20190814,Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine,,COSETTE PHARMACEUTICALS INC,1983/10/30-,0713-0166,3G6A5W338E; MRU5XH3B48,CAFFEINE; ERGOTAMINE TARTRATE,CAFFEINE; ERGOTAMINE,3G6A5W338E; PR834Q503T,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3a31ad0c-7bdd-544b-f5df-a99d04cf541c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a31ad0c-7bdd-544b-f5df-a99d04cf541c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a31ad0c-7bdd-544b-f5df-a99d04cf541c,3a31ad0c-7bdd-544b-f5df-a99d04cf541c
HUMAN PRESCRIPTION DRUG LABEL,SUPPOSITORY,RECTAL,ANDA,86557,Migergot,ERGOTAMINE TARTRATE AND CAFFEINE,20180130,Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine,,HORIZON PHARMA INC,1983/10/30-,75987-090,3G6A5W338E; MRU5XH3B48,CAFFEINE; ERGOTAMINE TARTRATE,CAFFEINE; ERGOTAMINE,3G6A5W338E; PR834Q503T,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4ae331e0-009a-477e-8408-6118dc620634/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ae331e0-009a-477e-8408-6118dc620634,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ae331e0-009a-477e-8408-6118dc620634,4ae331e0-009a-477e-8408-6118dc620634
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,ANDA,40590,ergotamine tartrate and caffeine,ERGOTAMINE TARTRATE AND CAFFEINE,20171218,Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine,,CINTEX SERVICES LLC,2016/11/23-,24470-917,3G6A5W338E; MRU5XH3B48,CAFFEINE; ERGOTAMINE TARTRATE,CAFFEINE; ERGOTAMINE,3G6A5W338E; PR834Q503T,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/41f88ae7-c124-5b9c-e054-00144ff88e88/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41f88ae7-c124-5b9c-e054-00144ff88e88,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=41f88ae7-c124-5b9c-e054-00144ff88e88,41f88ae7-c124-5b9c-e054-00144ff88e88
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,ANDA,40590,ergotamine tartrate and caffeine,ERGOTAMINE TARTRATE AND CAFFEINE,20150831,Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine,,MIKART INC,2005/09/16-,46672-198,3G6A5W338E; MRU5XH3B48,CAFFEINE; ERGOTAMINE TARTRATE,CAFFEINE; ERGOTAMINE,3G6A5W338E; PR834Q503T,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6a105e44-b558-45c1-9c91-fe1f3dfc5bd5/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a105e44-b558-45c1-9c91-fe1f3dfc5bd5,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a105e44-b558-45c1-9c91-fe1f3dfc5bd5,6a105e44-b558-45c1-9c91-fe1f3dfc5bd5
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,ANDA,40510,ERGOTAMINE,ERGOTAMINE TARTRATE AND CAFFEINE,20130410,Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine,,WEST WARD PHARMACEUTICAL CORP,2004/09/17-,0143-2120,3G6A5W338E; MRU5XH3B48,CAFFEINE; ERGOTAMINE TARTRATE,CAFFEINE; ERGOTAMINE,3G6A5W338E; PR834Q503T,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/19479eeb-f507-48a8-bca3-c9cc0a0f6021/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=19479eeb-f507-48a8-bca3-c9cc0a0f6021,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=19479eeb-f507-48a8-bca3-c9cc0a0f6021,19479eeb-f507-48a8-bca3-c9cc0a0f6021
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,ANDA,84294,Cafergot,ERGOTAMINE TARTRATE AND CAFFEINE,20120514,Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine,,SANDOZ INC,1982/01/01-,0781-5405,3G6A5W338E; MRU5XH3B48,CAFFEINE; ERGOTAMINE TARTRATE,CAFFEINE; ERGOTAMINE,3G6A5W338E; PR834Q503T,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b4a06de6-f837-43a8-ae7a-aadb38dd2a7d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4a06de6-f837-43a8-ae7a-aadb38dd2a7d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b4a06de6-f837-43a8-ae7a-aadb38dd2a7d,b4a06de6-f837-43a8-ae7a-aadb38dd2a7d
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; TABLET, CHEWABLE",ORAL,NDA,021977;208510,Vyvanse,LISDEXAMFETAMINE DIMESYLATE,20180119,Central Nervous System Stimulant,2007,SHIRE LLC,2007/02/23-; 2007/12/10-; 2014/08/30-; 2017/01/28-,59417-101; 59417-102; 59417-103; 59417-104; 59417-105; 59417-106; 59417-107; 59417-115; 59417-116; 59417-117; 59417-118; 59417-119; 59417-120,SJT761GEGS,LISDEXAMFETAMINE DIMESYLATE,LISDEXAMFETAMINE,H645GUL8KJ,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/704e4378-ca83-445c-8b45-3cfa51c1ecad/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=704e4378-ca83-445c-8b45-3cfa51c1ecad,704e4378-ca83-445c-8b45-3cfa51c1ecad
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,21977,Vyvanse,LISDEXAMFETAMINE DIMESYLATE,20120113,Central Nervous System Stimulant,2007,PHYSICIANS TOTAL CARE INC,2008/07/11-; 2009/03/20-; 2010/03/04-,54868-3655; 54868-5827; 54868-5916; 54868-6009,SJT761GEGS,LISDEXAMFETAMINE DIMESYLATE,LISDEXAMFETAMINE,H645GUL8KJ,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a310fc51-2743-4755-8398-fed5402283f6/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a310fc51-2743-4755-8398-fed5402283f6,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a310fc51-2743-4755-8398-fed5402283f6,a310fc51-2743-4755-8398-fed5402283f6
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,91189,Methamphetamine Hydrochloride,METHAMPHETAMINE HYDROCHLORIDE,20190815,Amphetamine Anorectic; Central Nervous System Stimulant,,MAYNE PHARMA INC,2010/04/26-,68308-115,997F43Z9CV,METHAMPHETAMINE HYDROCHLORIDE,Methamphetamine,44RAL3456C,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f31f580f-1f08-4a0f-b078-0b9e3308f712/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f31f580f-1f08-4a0f-b078-0b9e3308f712,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f31f580f-1f08-4a0f-b078-0b9e3308f712,f31f580f-1f08-4a0f-b078-0b9e3308f712
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,5378,Desoxyn,METHAMPHETAMINE HYDROCHLORIDE,20190423,Amphetamine Anorectic; Central Nervous System Stimulant,,RECORDATI RARE DISEASES INC,1943/12/31-; completed:1943/12/31-2017/08/19,55292-102; 55292-104,997F43Z9CV,METHAMPHETAMINE HYDROCHLORIDE,METHAMPHETAMINE,44RAL3456C,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f03a68d5-ed00-8a2d-af68-28be909ea85f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f03a68d5-ed00-8a2d-af68-28be909ea85f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f03a68d5-ed00-8a2d-af68-28be909ea85f,f03a68d5-ed00-8a2d-af68-28be909ea85f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,203846,Methamphetamine Hydrochloride,METHAMPHETAMINE HYDROCHLORIDE,20170801,Amphetamine Anorectic; Central Nervous System Stimulant,,WEST WARD PHARMACEUTICALS CORP,2016/12/06-,0054-0389,997F43Z9CV,METHAMPHETAMINE HYDROCHLORIDE,METHAMPHETAMINE,44RAL3456C,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/90c02ac6-e5e2-4c97-8c68-81e4e389a195/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90c02ac6-e5e2-4c97-8c68-81e4e389a195,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90c02ac6-e5e2-4c97-8c68-81e4e389a195,90c02ac6-e5e2-4c97-8c68-81e4e389a195
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21284,Methylphenidate,METHYLPHENIDATE,20190117,Central Nervous System Stimulant,1955,SANDOZ INC,2015/11/24-,0781-2361; 0781-2362; 0781-2363; 0781-2364,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1f8983ce-71b8-4c62-830d-e4692ddededa/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f8983ce-71b8-4c62-830d-e4692ddededa,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1f8983ce-71b8-4c62-830d-e4692ddededa,1f8983ce-71b8-4c62-830d-e4692ddededa
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,21514,Daytrana,METHYLPHENIDATE,20181102,Central Nervous System Stimulant,2006,NOVEN THERAPEUTICS LLC,2006/04/06-,68968-5552; 68968-5553; 68968-5554; 68968-5555,207ZZ9QZ49,METHYLPHENIDATE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/2c312c31-3198-4775-91ab-294e0b4b9e7f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c312c31-3198-4775-91ab-294e0b4b9e7f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c312c31-3198-4775-91ab-294e0b4b9e7f,2c312c31-3198-4775-91ab-294e0b4b9e7f
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,205489,Cotempla XR-ODT,METHYLPHENIDATE,20170628,Central Nervous System Stimulant,1955,NEOS THERAPEUTICS LP,2016/06/20-,70165-100; 70165-200; 70165-300,207ZZ9QZ49,Methylphenidate,Methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/33f70f58-c871-42c8-8adb-345caeafefcd/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33f70f58-c871-42c8-8adb-345caeafefcd,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33f70f58-c871-42c8-8adb-345caeafefcd,33f70f58-c871-42c8-8adb-345caeafefcd
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,21121,CONCERTA,METHYLPHENIDATE HYDROCHLORIDE,20190815,Central Nervous System Stimulant,2000,JANSSEN PHARMACEUTICALS INC,2000/08/01-,50458-585; 50458-586; 50458-587; 50458-588,4B3SC438HI,Methylphenidate hydrochloride,Methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1a88218c-5b18-4220-8f56-526de1a276cd/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a88218c-5b18-4220-8f56-526de1a276cd,1a88218c-5b18-4220-8f56-526de1a276cd
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,ANDA,204772,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE HYDROCHLORIDE,20190814,Central Nervous System Stimulant,,ALVOGEN INC,2017/10/20-,47781-540; 47781-541,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE; methylphenidate hydrochloride,METHYLPHENIDATE; methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/5ae0ac6f-7ea6-af8c-a697-4a68b38b3181/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ae0ac6f-7ea6-af8c-a697-4a68b38b3181,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5ae0ac6f-7ea6-af8c-a697-4a68b38b3181,5ae0ac6f-7ea6-af8c-a697-4a68b38b3181
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,91601,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20190802,Central Nervous System Stimulant,,TRIS PHARMA INC,2015/03/04-,27808-058; 27808-059,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e817377f-bc72-415a-acd2-7136746b2479/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e817377f-bc72-415a-acd2-7136746b2479,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e817377f-bc72-415a-acd2-7136746b2479,e817377f-bc72-415a-acd2-7136746b2479
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,205105,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20190618,Central Nervous System Stimulant,,AMNEAL PHARMACEUTICALS OF NEW YORK LLC,2016/09/20-,0115-1736; 0115-1737; 0115-1738; 0115-1739; 0115-1740; 0115-1741,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/10aa0dc0-bd0e-4927-a19a-8722d78ad67d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10aa0dc0-bd0e-4927-a19a-8722d78ad67d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10aa0dc0-bd0e-4927-a19a-8722d78ad67d,10aa0dc0-bd0e-4927-a19a-8722d78ad67d
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, CHEWABLE",ORAL,ANDA,204115,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20190611,Central Nervous System Stimulant,,LUPIN PHARMACEUTICALS INC,2015/04/06-,43386-570; 43386-571; 43386-572,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/5bfe50ed-171f-4c40-bc0b-20c68e8e2025/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bfe50ed-171f-4c40-bc0b-20c68e8e2025,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5bfe50ed-171f-4c40-bc0b-20c68e8e2025,5bfe50ed-171f-4c40-bc0b-20c68e8e2025
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,207416,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE HYDROCHLORIDE,20190524,Central Nervous System Stimulant,1955,CAMBER PHARMACEUTICAL INC,2015/10/01-,31722-173; 31722-174; 31722-175,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/778190da-1528-4def-94bf-ee23ee5268a5/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=778190da-1528-4def-94bf-ee23ee5268a5,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=778190da-1528-4def-94bf-ee23ee5268a5,778190da-1528-4def-94bf-ee23ee5268a5
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA authorized generic,21121,methylphenidate hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20190516,Central Nervous System Stimulant,2000,ACTAVIS PHARMA INC,completed:2011/04/01-2021/09/30,0591-2715; 0591-2716; 0591-2717; 0591-2718,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/038ae416-4bd5-411b-bd28-d4f0af5c2ab7/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=038ae416-4bd5-411b-bd28-d4f0af5c2ab7,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=038ae416-4bd5-411b-bd28-d4f0af5c2ab7,038ae416-4bd5-411b-bd28-d4f0af5c2ab7
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,10187,Ritalin,METHYLPHENIDATE HYDROCHLORIDE,20190516,Central Nervous System Stimulant,1955,NOVARTIS PHARMACEUTICALS CORPORATION,1955/12/31-,0078-0439; 0078-0440; 0078-0441,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c0bf0835-6a2f-4067-a158-8b86c4b0668a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0bf0835-6a2f-4067-a158-8b86c4b0668a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0bf0835-6a2f-4067-a158-8b86c4b0668a,c0bf0835-6a2f-4067-a158-8b86c4b0668a
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40300,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20190513,Central Nervous System Stimulant,,AMERICAN HEALTH PACKAGING,2014/07/31-; completed:2014/07/31-2018/09/30,68084-805; 68084-823; 68084-860,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/eb9b7377-d918-43fb-8e82-d14c85ed64a8/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb9b7377-d918-43fb-8e82-d14c85ed64a8,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eb9b7377-d918-43fb-8e82-d14c85ed64a8,eb9b7377-d918-43fb-8e82-d14c85ed64a8
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA authorized generic,010187;018029,Methylphenidate Hydrochloride; Methylphenidate Hydrochloride SR,METHYLPHENIDATE HYDROCHLORIDE,20190227,Central Nervous System Stimulant,,SANDOZ INC,completed:1955/12/31-2021/02/28; completed:1955/12/31-2022/05/31; completed:1982/03/31-2017/04/30,0781-5748; 0781-5749; 0781-5753; 0781-5754,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4e50d72b-9437-4a23-b2f3-f7a43ad3934e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e50d72b-9437-4a23-b2f3-f7a43ad3934e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e50d72b-9437-4a23-b2f3-f7a43ad3934e,4e50d72b-9437-4a23-b2f3-f7a43ad3934e
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,21284,Ritalin LA,METHYLPHENIDATE HYDROCHLORIDE,20190131,Central Nervous System Stimulant,1955,NOVARTIS PHARMACEUTICALS CORPORATION,2002/06/05-,0078-0370; 0078-0371; 0078-0372; 0078-0424,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/effd952d-ac94-47bb-b107-589a4934dcca/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=effd952d-ac94-47bb-b107-589a4934dcca,effd952d-ac94-47bb-b107-589a4934dcca
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,90710,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20190129,Central Nervous System Stimulant,1955,SUN PHARMACEUTICAL INDUSTRIES INC,2013/08/16-,57664-228; 57664-229; 57664-230,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1a89b390-0cd5-45cb-9e70-20de44652c56/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a89b390-0cd5-45cb-9e70-20de44652c56,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a89b390-0cd5-45cb-9e70-20de44652c56,1a89b390-0cd5-45cb-9e70-20de44652c56
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,207485,Methylphenidate,METHYLPHENIDATE HYDROCHLORIDE,20181219,Central Nervous System Stimulant,,KVK TECH INC,2016/11/21-,10702-163; 10702-164,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/2cf1b26b-199d-4c7f-ab64-4805a9def2cc/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2cf1b26b-199d-4c7f-ab64-4805a9def2cc,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2cf1b26b-199d-4c7f-ab64-4805a9def2cc,2cf1b26b-199d-4c7f-ab64-4805a9def2cc
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,206932,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20181219,Central Nervous System Stimulant,,KVK TECH INC,2017/05/11-,10702-100; 10702-101; 10702-102,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/1bf37f9f-29cf-4b09-9c81-eb369e35a042/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1bf37f9f-29cf-4b09-9c81-eb369e35a042,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1bf37f9f-29cf-4b09-9c81-eb369e35a042,1bf37f9f-29cf-4b09-9c81-eb369e35a042
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,201466,methylphenidate hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20181213,Central Nervous System Stimulant,,BRECKENRIDGE PHARMACEUTICAL INC,2017/11/01-,51991-611; 51991-612,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e0a3cc3c-db6f-4693-9ad5-2b719b62fd92/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0a3cc3c-db6f-4693-9ad5-2b719b62fd92,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e0a3cc3c-db6f-4693-9ad5-2b719b62fd92,e0a3cc3c-db6f-4693-9ad5-2b719b62fd92
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,21419,Methylin,METHYLPHENIDATE HYDROCHLORIDE,20181206,Central Nervous System Stimulant,,SHIONOGI INC,2010/11/01-,59630-750; 59630-755,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9e3c22d9-71d9-46a7-b315-8021c94c4bec/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e3c22d9-71d9-46a7-b315-8021c94c4bec,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e3c22d9-71d9-46a7-b315-8021c94c4bec,9e3c22d9-71d9-46a7-b315-8021c94c4bec
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,205105,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20181127,Central Nervous System Stimulant,,COREPHARMA LLC,completed:2016/09/20-2019/10/01; completed:2016/09/20-2019/11/01; completed:2016/09/20-2019/12/01,64720-401; 64720-402; 64720-403; 64720-404; 64720-405; 64720-406,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/bce4cf37-d6a3-4203-b45d-6d1c35510eec/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bce4cf37-d6a3-4203-b45d-6d1c35510eec,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bce4cf37-d6a3-4203-b45d-6d1c35510eec,bce4cf37-d6a3-4203-b45d-6d1c35510eec
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, CHEWABLE",ORAL,ANDA,210354,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20181123,Central Nervous System Stimulant,,CAMBER PHARMACEUTICALS INC,2018/03/01-,31722-926; 31722-927; 31722-928,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/bb73cd3e-aa7c-4f7e-826d-75e71fb6d1e0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb73cd3e-aa7c-4f7e-826d-75e71fb6d1e0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bb73cd3e-aa7c-4f7e-826d-75e71fb6d1e0,bb73cd3e-aa7c-4f7e-826d-75e71fb6d1e0
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA authorized generic,21419,Methylphenidate HCl Oral Solution,METHYLPHENIDATE HYDROCHLORIDE,20181105,Central Nervous System Stimulant,,SPECGX LLC,2013/08/01-,0406-3005; 0406-3010,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/7b372d74-7ba7-437a-be8c-6e8335b78818/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b372d74-7ba7-437a-be8c-6e8335b78818,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b372d74-7ba7-437a-be8c-6e8335b78818,7b372d74-7ba7-437a-be8c-6e8335b78818
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,ANDA,205327,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20181024,Central Nervous System Stimulant,2000,TRIGEN LABORATORIES LLC,2017/08/14-; 2017/12/29-,13811-706; 13811-707; 13811-708; 13811-709; 13811-710,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f,c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,209753,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE HYDROCHLORIDE,20181012,Central Nervous System Stimulant,,BIONPHARMA INC,2018/03/21-,69452-165; 69452-166; 69452-167,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3fe86f60-9a58-43d6-b955-c698ddcc95d0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fe86f60-9a58-43d6-b955-c698ddcc95d0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3fe86f60-9a58-43d6-b955-c698ddcc95d0,3fe86f60-9a58-43d6-b955-c698ddcc95d0
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA authorized generic,21121,methylphenidate hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20180914,Central Nervous System Stimulant,2000,AMERICAN HEALTH PACKAGING,2014/08/21-; completed:2016/05/12-2017/10/31,68084-816; 68084-829; 68084-833; 68084-890,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/15b53374-8d97-496b-9561-1f4f3568926b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15b53374-8d97-496b-9561-1f4f3568926b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=15b53374-8d97-496b-9561-1f4f3568926b,15b53374-8d97-496b-9561-1f4f3568926b
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,078458;200886,Methylphenidate Hydrochloride (LA),METHYLPHENIDATE HYDROCHLORIDE,20180320,Central Nervous System Stimulant,,MAYNE PHARMA,2016/08/03-; 2017/02/20-; 2018/02/27-,51862-262; 51862-263; 51862-264; 51862-265; 51862-267,4B3SC438HI,Methylphenidate Hydrochloride,Methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/127b4225-7d95-43e6-9514-cc1c7d1fbf9b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=127b4225-7d95-43e6-9514-cc1c7d1fbf9b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=127b4225-7d95-43e6-9514-cc1c7d1fbf9b,127b4225-7d95-43e6-9514-cc1c7d1fbf9b
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, EXTENDED RELEASE",ORAL,ANDA,040300;075629,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20180219,Central Nervous System Stimulant,,SPECGX LLC,2011/03/18-,0406-1142; 0406-1144; 0406-1146; 0406-1445; 0406-1473,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/981a2ad8-33f7-4678-9162-9df9685bd4a6/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=981a2ad8-33f7-4678-9162-9df9685bd4a6,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=981a2ad8-33f7-4678-9162-9df9685bd4a6,981a2ad8-33f7-4678-9162-9df9685bd4a6
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,202608,Methylphenidate Hydrochloride Extended-Release,METHYLPHENIDATE HYDROCHLORIDE,20180213,Central Nervous System Stimulant,2000,SPECGX LLC,2012/12/28-; 2013/03/13-; 2013/03/25-,0406-0127; 0406-0136; 0406-0154,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b1b0f2ff-d9df-42ab-b471-226ecf97e075/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1b0f2ff-d9df-42ab-b471-226ecf97e075,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1b0f2ff-d9df-42ab-b471-226ecf97e075,b1b0f2ff-d9df-42ab-b471-226ecf97e075
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,ANDA,203583,Methylphenidate Hydrochloride Extended-Release,METHYLPHENIDATE HYDROCHLORIDE,20180119,Central Nervous System Stimulant,,SPECGX LLC,2015/09/29-,0406-1810; 0406-1820; 0406-1830; 0406-1840; 0406-1850; 0406-1860,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9e11e093-4ff3-4bed-8fe9-3ee460b47303/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e11e093-4ff3-4bed-8fe9-3ee460b47303,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e11e093-4ff3-4bed-8fe9-3ee460b47303,9e11e093-4ff3-4bed-8fe9-3ee460b47303
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,78458,Methylphenidate Hydrochloride (LA),METHYLPHENIDATE HYDROCHLORIDE,20180108,Central Nervous System Stimulant,,TEVA PHARMACEUTICALS USA INC,2018/01/02-,0093-3230; 0093-3231; 0093-3232,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/4b9517d2-d26b-439c-b19e-b7932c403247/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b9517d2-d26b-439c-b19e-b7932c403247,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b9517d2-d26b-439c-b19e-b7932c403247,4b9517d2-d26b-439c-b19e-b7932c403247
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,207884,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20171109,Central Nervous System Stimulant,,LUPIN PHARMACEUTICALS INC,2015/11/13-; 2016/01/20-,43386-573; 43386-574; 43386-575,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/ec8a8896-077d-4dee-9e10-97172512c5ed/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec8a8896-077d-4dee-9e10-97172512c5ed,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ec8a8896-077d-4dee-9e10-97172512c5ed,ec8a8896-077d-4dee-9e10-97172512c5ed
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,204602,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20171031,Central Nervous System Stimulant,,LUPIN PHARMACEUTICALS INC,2015/12/15-,43386-930; 43386-931,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/57fd619e-687d-403c-a77a-3dc3a1bab65a/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57fd619e-687d-403c-a77a-3dc3a1bab65a,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=57fd619e-687d-403c-a77a-3dc3a1bab65a,57fd619e-687d-403c-a77a-3dc3a1bab65a
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION, EXTENDED RELEASE",ORAL,NDA,202100,Quillivant XR,METHYLPHENIDATE HYDROCHLORIDE,20171017,Central Nervous System Stimulant,1955,NEXTWAVE PHARMACEUTICALS INC,2012/10/01-; 2013/01/04-,24478-190; 24478-200; 24478-205; 24478-210,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e0157005-6e3e-4763-b910-9eb0937608c9/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0157005-6e3e-4763-b910-9eb0937608c9,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e0157005-6e3e-4763-b910-9eb0937608c9,e0157005-6e3e-4763-b910-9eb0937608c9
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA,206726,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20170829,Central Nervous System Stimulant,2000,MYLAN PHARMACEUTICALS INC,2016/12/29-,0378-8155; 0378-8156; 0378-8157; 0378-8158,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f201c037-5cc8-45e7-a310-b1f63e1d1d74/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f201c037-5cc8-45e7-a310-b1f63e1d1d74,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f201c037-5cc8-45e7-a310-b1f63e1d1d74,f201c037-5cc8-45e7-a310-b1f63e1d1d74
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,ANDA,207515,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20170627,Central Nervous System Stimulant,2000,AMNEAL PHARMACEUTICALS LLC,2018/02/02-,65162-231; 65162-233; 65162-235; 65162-237,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/34de1806-d921-4d2f-8c7f-03625b717a70/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34de1806-d921-4d2f-8c7f-03625b717a70,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=34de1806-d921-4d2f-8c7f-03625b717a70,34de1806-d921-4d2f-8c7f-03625b717a70
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,077707;078873,Methylphenidate Hydrochloride (CD),METHYLPHENIDATE HYDROCHLORIDE,20170524,Central Nervous System Stimulant,,TEVA PHARMACEUTICALS USA INC,2012/09/27-,0093-5292; 0093-5293; 0093-5295; 0093-5296; 0093-5297; 0093-5298,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/b7941137-6f70-4501-9428-de726b3e7ae8/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7941137-6f70-4501-9428-de726b3e7ae8,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7941137-6f70-4501-9428-de726b3e7ae8,b7941137-6f70-4501-9428-de726b3e7ae8
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,ANDA,89601,Metadate ER,METHYLPHENIDATE HYDROCHLORIDE,20170522,Central Nervous System Stimulant,,UPSTATE PHARMA LLC,2014/11/01-,65580-594,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/084f8412-dab8-4418-91dd-06655cd00206/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=084f8412-dab8-4418-91dd-06655cd00206,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=084f8412-dab8-4418-91dd-06655cd00206,084f8412-dab8-4418-91dd-06655cd00206
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,085799;086428;086429,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20170522,Central Nervous System Stimulant,,UPSTATE PHARMA LLC,2014/11/01-,65580-530; 65580-531; 65580-532,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/0945cdf5-0c86-45ed-88cd-d4e7eb12ac6e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0945cdf5-0c86-45ed-88cd-d4e7eb12ac6e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0945cdf5-0c86-45ed-88cd-d4e7eb12ac6e,0945cdf5-0c86-45ed-88cd-d4e7eb12ac6e
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA authorized generic,10187,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20170522,Central Nervous System Stimulant,,BRYANT RANCH PREPACK,1955/12/31-,63629-3166,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/88852b48-44eb-2c21-5f85-fd2b66376b80/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88852b48-44eb-2c21-5f85-fd2b66376b80,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=88852b48-44eb-2c21-5f85-fd2b66376b80,88852b48-44eb-2c21-5f85-fd2b66376b80
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,202892,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20170222,Central Nervous System Stimulant,,PAR PHARMACEUTICAL,completed:2014/09/23-2021/02/28; completed:2014/09/23-2021/04/30; completed:2014/09/23-2021/05/31,0603-4576; 0603-4577; 0603-4578,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e6f6e86b-01f4-42eb-9054-42c8be1797c8/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6f6e86b-01f4-42eb-9054-42c8be1797c8,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6f6e86b-01f4-42eb-9054-42c8be1797c8,e6f6e86b-01f4-42eb-9054-42c8be1797c8
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,ANDA,91695,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20170131,Central Nervous System Stimulant,2000,LANNETT COMPANY INC,2013/07/10-; 2013/09/23-,62175-310; 62175-311; 62175-312; 62175-313,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/3d1f5aff-5d39-496c-b5ed-7f3c70ec641c/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d1f5aff-5d39-496c-b5ed-7f3c70ec641c,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3d1f5aff-5d39-496c-b5ed-7f3c70ec641c,3d1f5aff-5d39-496c-b5ed-7f3c70ec641c
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA,79031,Methylphenidate Hydrochloride (LA),METHYLPHENIDATE HYDROCHLORIDE,20170126,Central Nervous System Stimulant,,TEVA PHARMACEUTICALS USA INC,2012/07/16-,0093-5346; 0093-5347; 0093-5348,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/034fb7cd-e183-475e-8beb-64fd88facc8f/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=034fb7cd-e183-475e-8beb-64fd88facc8f,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=034fb7cd-e183-475e-8beb-64fd88facc8f,034fb7cd-e183-475e-8beb-64fd88facc8f
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA authorized generic,21259,methylphenidate hydrochloride CD,METHYLPHENIDATE HYDROCHLORIDE,20170118,Central Nervous System Stimulant,,KREMERS URBAN PHARMACEUTICALS INC,2003/02/18-; 2003/07/22-; 2003/08/12-; 2006/03/21-,62175-151; 62175-152; 62175-153; 62175-154; 62175-155; 62175-156,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/fe0290cd-d183-4a29-a876-d3bd421d9e72/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe0290cd-d183-4a29-a876-d3bd421d9e72,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe0290cd-d183-4a29-a876-d3bd421d9e72,fe0290cd-d183-4a29-a876-d3bd421d9e72
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,21259,Metadate CD,METHYLPHENIDATE HYDROCHLORIDE,20161011,Central Nervous System Stimulant,,UNITHER MANUFACTURING LLC,2003/02/18-; 2003/07/22-; 2003/08/12-; 2006/03/21-,53014-579; 53014-580; 53014-581; 53014-582; 53014-583; 53014-584,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a6aedc40-5725-4bd3-9037-033746e8599e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6aedc40-5725-4bd3-9037-033746e8599e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a6aedc40-5725-4bd3-9037-033746e8599e,a6aedc40-5725-4bd3-9037-033746e8599e
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40220,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20161001,Central Nervous System Stimulant,,ACTAVIS PHARMA INC,completed:1990/01/01-2020/01/31; completed:1990/01/01-2020/02/29; completed:1990/01/01-2020/04/30,0591-5882; 0591-5883; 0591-5884,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/a7713510-2a7c-4c34-9fc2-a96fcdd52891/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7713510-2a7c-4c34-9fc2-a96fcdd52891,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7713510-2a7c-4c34-9fc2-a96fcdd52891,a7713510-2a7c-4c34-9fc2-a96fcdd52891
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, CHEWABLE",ORAL,ANDA,204115,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20160201,Central Nervous System Stimulant,,NOVEL LABORATORIES INC,2015/02/25-,40032-570; 40032-571; 40032-572,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/16508cc6-13c7-4088-927a-b7206eb7c633/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16508cc6-13c7-4088-927a-b7206eb7c633,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=16508cc6-13c7-4088-927a-b7206eb7c633,16508cc6-13c7-4088-927a-b7206eb7c633
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,207884,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20160105,Central Nervous System Stimulant,,NOVEL LABORATORIES INC,2015/11/13-,40032-573; 40032-574; 40032-575,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/e5e705f5-e4f2-46c0-a157-1b4f7413807e/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5e705f5-e4f2-46c0-a157-1b4f7413807e,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5e705f5-e4f2-46c0-a157-1b4f7413807e,e5e705f5-e4f2-46c0-a157-1b4f7413807e
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,ANDA,204602,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20150827,Central Nervous System Stimulant,,NOVEL LABORATORIES INC,2015/08/14-,40032-930; 40032-931,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/99981332-4ec7-4260-aa15-cfe38945ff23/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99981332-4ec7-4260-aa15-cfe38945ff23,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99981332-4ec7-4260-aa15-cfe38945ff23,99981332-4ec7-4260-aa15-cfe38945ff23
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,085799;086428;086429,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20140106,Central Nervous System Stimulant,,UNITHER MANUFACTURING LLC,1977/12/23-; 1979/04/04-,53014-530; 53014-531; 53014-532,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f04e8194-7077-42cf-99ee-b61e42a76cf0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f04e8194-7077-42cf-99ee-b61e42a76cf0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f04e8194-7077-42cf-99ee-b61e42a76cf0,f04e8194-7077-42cf-99ee-b61e42a76cf0
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,ANDA,89601,Metadate ER,METHYLPHENIDATE HYDROCHLORIDE,20140106,Central Nervous System Stimulant,,UNITHER MANUFACTURING LLC,1988/06/01-,53014-594,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/739bbd64-d9e1-4771-967b-a2cd08f4eaf5/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=739bbd64-d9e1-4771-967b-a2cd08f4eaf5,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=739bbd64-d9e1-4771-967b-a2cd08f4eaf5,739bbd64-d9e1-4771-967b-a2cd08f4eaf5
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,10187,Ritalin,METHYLPHENIDATE HYDROCHLORIDE,20120120,Central Nervous System Stimulant,,PHYSICIANS TOTAL CARE INC,2000/03/10-; completed:1955/12/31-2011/06/30,54868-1706; 54868-2762,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/cd83fc91-47a3-4be4-9727-caf9ec0371e8/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd83fc91-47a3-4be4-9727-caf9ec0371e8,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd83fc91-47a3-4be4-9727-caf9ec0371e8,cd83fc91-47a3-4be4-9727-caf9ec0371e8
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA authorized generic,21121,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20110516,Central Nervous System Stimulant,2000,PHYSICIANS TOTAL CARE INC,2011/06/01-,54868-6261; 54868-6262,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/2bfb390f-ba99-4d21-8a9e-50fa8ec217c0/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2bfb390f-ba99-4d21-8a9e-50fa8ec217c0,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2bfb390f-ba99-4d21-8a9e-50fa8ec217c0,2bfb390f-ba99-4d21-8a9e-50fa8ec217c0
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,21259,Metadate CD,METHYLPHENIDATE HYDROCHLORIDE,20101101,Central Nervous System Stimulant,,PHYSICIANS TOTAL CARE INC,2002/12/23-; 2005/08/26-; 2011/03/02-,54868-0668; 54868-4718; 54868-5397; 54868-6234,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/be6f8d00-9281-4f67-b8fc-3de58a4d14f4/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be6f8d00-9281-4f67-b8fc-3de58a4d14f4,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be6f8d00-9281-4f67-b8fc-3de58a4d14f4,be6f8d00-9281-4f67-b8fc-3de58a4d14f4
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,21121,Concerta,METHYLPHENIDATE HYDROCHLORIDE,20101101,Central Nervous System Stimulant,2000,PHYSICIANS TOTAL CARE INC,2003/03/20-; 2003/03/21-; 2003/05/08-; 2003/11/13-,54868-4489; 54868-4759; 54868-4789; 54868-4957,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f63155b9-ea71-4a30-be32-37173f87bcbf/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f63155b9-ea71-4a30-be32-37173f87bcbf,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f63155b9-ea71-4a30-be32-37173f87bcbf,f63155b9-ea71-4a30-be32-37173f87bcbf
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,ANDA,86428,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20100616,Central Nervous System Stimulant,,PHYSICIANS TOTAL CARE INC,1994/12/16-,54868-3454,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/f931d3af-c32a-4406-8799-9b097f41594b/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f931d3af-c32a-4406-8799-9b097f41594b,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f931d3af-c32a-4406-8799-9b097f41594b,f931d3af-c32a-4406-8799-9b097f41594b
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40300,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE HYDROCHLORIDE,20100201,Central Nervous System Stimulant,,BRYANT RANCH PREPACK,2010/02/01-,63629-3279,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/0fcdbdb5-4b27-4ef8-aa1c-b72d355def41/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fcdbdb5-4b27-4ef8-aa1c-b72d355def41,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0fcdbdb5-4b27-4ef8-aa1c-b72d355def41,0fcdbdb5-4b27-4ef8-aa1c-b72d355def41
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40220,Methylphenidate,METHYLPHENIDATE HYDROCHLORIDE,20091016,Central Nervous System Stimulant,,PHYSICIANS TOTAL CARE INC,2005/03/24-; 2007/10/16-; 2009/05/14-,54868-0733; 54868-1704; 54868-2974,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/330e620f-4b7f-4101-91dd-feddb7a823ed/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=330e620f-4b7f-4101-91dd-feddb7a823ed,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=330e620f-4b7f-4101-91dd-feddb7a823ed,330e620f-4b7f-4101-91dd-feddb7a823ed
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,40220,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,20090522,Central Nervous System Stimulant,,STAT RX USA LLC,1997/08/29-,16590-837,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d356f9f6-d094-478d-bf79-7781490588cc/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d356f9f6-d094-478d-bf79-7781490588cc,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d356f9f6-d094-478d-bf79-7781490588cc,d356f9f6-d094-478d-bf79-7781490588cc
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, EXTENDED RELEASE",ORAL,,,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,20060919,Central Nervous System Stimulant,,UCB PHARMA INC,,0781-8840; 0781-8841; 0781-8842; 0781-8843,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/6281ca7c-2aec-4f14-b7e4-82401a701c96/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6281ca7c-2aec-4f14-b7e4-82401a701c96,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6281ca7c-2aec-4f14-b7e4-82401a701c96,6281ca7c-2aec-4f14-b7e4-82401a701c96
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,ANDA,207488,METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE,METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE,20181219,Central Nervous System Stimulant,,KVK TECH INC,2015/06/09-,10702-075; 10702-076,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/be8580bc-0eb2-4eb6-a4cc-4ebbeb33424d/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be8580bc-0eb2-4eb6-a4cc-4ebbeb33424d,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be8580bc-0eb2-4eb6-a4cc-4ebbeb33424d,be8580bc-0eb2-4eb6-a4cc-4ebbeb33424d
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, MULTILAYER",ORAL,ANDA,74654,"Orphenadrine Citrate, Aspirin and Caffeine","ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE",20101022,Central Nervous System Stimulant; Methylxanthine; Muscle Relaxant; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,,REBEL DISTRIBUTORS CORP,1996/12/31-,21695-726,3G6A5W338E; R16CO5Y76E; X0A40N8I4S,ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE,ASPIRIN; CAFFEINE; ORPHENADRINE,3G6A5W338E; AL805O9OG9; R16CO5Y76E,http://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8e41b33e-f71f-4a5e-b88f-cdfefb2bee20/spl-doc,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e41b33e-f71f-4a5e-b88f-cdfefb2bee20,http://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e41b33e-f71f-4a5e-b88f-cdfefb2bee20,8e41b33e-f71f-4a5e-b88f-cdfefb2bee20